Targeted disruption of the c-src proto-oncogene in mice has shown that src expression is required for normal bone resorption, since the src-deficient mutants develop osteopetrosis. To evaluate the mechanisms by which src-deficiency affects osteoclast function, we treated src-deficient mice with the stimulants of bone resorption, IL-1, parathyroid hormone, and parathyroid hormone-related protein, and analyzed the effects by quantitative bone histomorphometry and electron microscopy. Increased numbers of multinucleated cells with the morphological characteristics of osteoclasts appeared on bone surfaces, but these cells did not form ruffled borders or normal resorption lacunae. To confirm these in vivo findings, we cultured src-mutant bone marrow cells on dentine slices in the presence of 1,25 dihydroxyvitamin D3. Increased numbers of multinucleated cells were formed, but unlike normal murine bone marrow cells, they did not form resorption pits. These results indicate that osteoclasts appear in the absence of pp60c-src, but that pp60c-src expression is required for mature osteoclasts to form ruffled borders and resorb bone.
B F Boyce, T Yoneda, C Lowe, P Soriano, G R Mundy
Title and authors | Publication | Year |
---|---|---|
Extracellular matrix: Dystroglycan interactions—Roles for the dystrophin‐associated glycoprotein complex in skeletal tissue dynamics
Hopkinson M, Pitsillides AA |
International Journal of Experimental Pathology | 2025 |
Exploring the mechanisms and targets of proton pump inhibitors-induced osteoporosis through network toxicology, molecular docking, and molecular dynamics simulations
Mu Y, Zhou Y, Zhang X, Shao Y |
Frontiers in Pharmacology | 2025 |
Formation of Membrane Domains via Actin Waves: A Fundamental Principle in the Generation of Dynamic Structures in Phagocytes
Takito J, Nonaka N |
International Journal of Molecular Sciences | 2025 |
Unraveling the intricacies of osteoclast differentiation and maturation: insight into novel therapeutic strategies for bone-destructive diseases.
Takegahara N, Kim H, Choi Y |
Experimental & molecular medicine | 2024 |
Biomaterial Cues for Regulation of Osteoclast Differentiation and Function in Bone Regeneration
Shariati K, Bedar M, Huang KX, Moghadam S, Mirzaie S, LaGuardia JS, Chen W, Kang Y, Ren X, Lee JC |
Advanced therapeutics | 2024 |
Suppressive effects of (-)-tubaic acid on RANKL-induced osteoclast differentiation and bone resorption.
Lim S, Ihn HJ, Kim JA, Bae JS, Kim JE, Bae YC, Shin HI, Kim TH, Park EK |
Animal Cells and Systems | 2023 |
Functional roles of SRC signaling in pancreatic cancer: Recent insights provide novel therapeutic opportunities.
Poh AR, Ernst M |
Oncogene | 2023 |
Tyrosine Kinase Src Is a Regulatory Factor of Bone Homeostasis
Matsubara T, Yasuda K, Mizuta K, Kawaue H, Kokabu S |
International journal of molecular sciences | 2022 |
Metastasis suppressor 1 controls osteoblast differentiation and bone homeostasis through regulating Src-Wnt/β-catenin signaling
Chen M, Shan L, Gan Y, Tian L, Zhou J, Zhu E, Yuan H, Li X, Wang B |
2022 | |
Protein phosphatase 1 regulatory subunit 18 suppresses the transcriptional activity of NFATc1 via regulation of c-fos
K Yasuda, T Matsubara, T Shirakawa, T Kawamoto, S Kokabu |
Bone Reports | 2021 |
Regulation of TNF-Induced Osteoclast Differentiation
Z Yao, S Getting, I Locke |
Cells | 2021 |
Tetraspanin 7 regulates osteoclast function through association with the RANK/αvβ3 integrin complex
M Kim, J Lin, JE Huh, JH Park, M Go, H Lee, D Hwang, HS Kim, T Kim, D Lee, SY Lee |
Journal of Cellular Physiology | 2021 |
Characterization of unique functionalities in c-Src domains required for osteoclast podosome belt formation
T Matsubara, WN Addison, S Kokabu, L Neff, W Horne, F Gori, R Baron |
The Journal of biological chemistry | 2021 |
Novel Majeed Syndrome–Causing LPIN2 Mutations Link Bone Inflammation to Inflammatory M2 Macrophages and Accelerated Osteoclastogenesis
F Bhuyan, AA Jesus, J Mitchell, E Leikina, R VanTries, R Herzog, KB Onel, A Oler, GA Sanchez, KA Johnson, L Bichell, B Marrero, LF Castro, Y Huang, KR Calvo, MT Collins, S Ganesan, LV Chernomordik, PJ Ferguson, R GoldbachMansky |
Arthritis & Rheumatology | 2021 |
Two macrophages, osteoclasts and microglia: from development to pleiotropy
JW Lee, IH Lee, T Iimura, SW Kong |
Bone Research | 2021 |
Beclin 1 positively regulates osteoprotegerin-induced inhibition of osteoclastogenesis by increasing autophagy in vitro
X Tong, W Min, S Li, M Chen, R Song, J Bian, J Gu, Z Liu |
Differentiation; research in biological diversity | 2021 |
Flavonoids: Classification, Function, and Molecular Mechanisms Involved in Bone Remodelling
P Ramesh, R Jagadeesan, S Sekaran, A Dhanasekaran, S Vimalraj |
Frontiers in Endocrinology | 2021 |
Hdac3 deletion in myeloid progenitor cells enhances bone healing in females and limits osteoclast fusion via Pmepa1
DH Molstad, E Zars, A Norton, KC Mansky, JJ Westendorf, EW Bradley |
Scientific Reports | 2020 |
Osteoclast Signal Transduction During Bone Metastasis Formation
DS Győri, A Mócsai |
Frontiers in Cell and Developmental Biology | 2020 |
PP121 suppresses RANKL-Induced osteoclast formation in vitro and LPS-Induced bone resorption in vivo
Z Zhou, X Chen, X Chen, A Qin, Y Mao, Y Pang, S Yu, S Zhang |
Experimental Cell Research | 2020 |
Targeting anti-cancer agents to bone using bisphosphonates
L Xing, FH Ebetino, RK Boeckman, V Srinivasan, J Tao, TK Sawyer, J Li, Z Yao, BF Boyce |
Bone | 2020 |
Plectin stabilizes microtubules during osteoclastic bone resorption by acting as a scaffold for Src and Pyk2
T Matsubara, T Yaginuma, WN Addison, Y Fujita, K Watanabe, I Yoshioka, H Hikiji, K Maki, R Baron, S Kokabu |
Bone | 2020 |
Cytoplasmic PCNA is located in the actin belt and involved in osteoclast differentiation
D Tang, X Liu, K Chen, Z Li, Y Dai, J Xu, HT Zhang, X Gao, L Liu |
Aging | 2020 |
The osteoclast, a target cell for microorganisms
B Raynaud-Messina, C Verollet, I Maridonneau-Parini |
Bone | 2019 |
RNA-based therapy for osteogenesis
P Wang, F Perche, D Logeart-Avramoglou, C Pichon |
International Journal of Pharmaceutics | 2019 |
RACK1 interaction with c-Src is essential for osteoclast function
JH Park, E Jeong, J Lin, R Ko, JH Kim, S Yi, Y Choi, IC Kang, D Lee, SY Lee |
Experimental & molecular medicine | 2019 |
CD55 Regulates Bone Mass in Mice by Modulating RANKL‐Mediated Rac Signaling and Osteoclast Function
B Shin, H Won, DJ Adams, SK Lee |
Journal of Bone and Mineral Research | 2019 |
Deficiency in the phosphatase PHLPP1 suppresses osteoclast-mediated bone resorption and enhances bone formation in mice
AM Mattson, DL Begun, DH Molstad, MA Meyer, MJ Oursler, JJ Westendorf, EW Bradley |
The Journal of biological chemistry | 2019 |
Alveolar Bone Protection by Targeting the SH3BP2‐SYK Axis in Osteoclasts
M Kittaka, T Yoshimoto, C Schlosser, R Rottapel, M Kajiya, H Kurihara, EJ Reichenberger, Y Ueki |
Journal of Bone and Mineral Research | 2019 |
Kif1c regulates osteoclastic bone resorption as a downstream molecule of p130Cas
M Kobayakawa, T Matsubara, A Mizokami, F Hiura, N Takakura, S Kokabu, M Matsuda, H Yasuda, I Nakamura, Y Takei, H Honda, R Hosokawa, E Jimi |
Cell Biochemistry and Function | 2019 |
Atlas of Immediate Dental Implant Loading
M Peñarrocha-Diago, U Covani, L Cuadrado |
2019 | |
Updating osteoimmunology: regulation of bone cells by innate and adaptive immunity
MC Walsh, N Takegahara, H Kim, Y Choi |
Nature Reviews Rheumatology | 2018 |
Recent advances in osteoclast biology
T Ono, T Nakashima |
Histochemistry and Cell Biology | 2018 |
Rab GTPases in Osteoclastic Endomembrane Systems
M Roy, S Roux |
BioMed Research International | 2018 |
Non-canonical Wnt signals regulate cytoskeletal remodeling in osteoclasts
S Uehara, N Udagawa, Y Kobayashi |
Cellular and Molecular Life Sciences | 2018 |
c-Src–Dependent and –Independent Functions of Matk in Osteoclasts and Osteoblasts
JH Kim, K Kim, I Kim, S Seong, N Kim |
Journal of immunology (Baltimore, Md. : 1950) | 2018 |
Systemic Activation of Activin A Signaling Causes Chronic Kidney Disease-Mineral Bone Disorder
T Sugatani |
International journal of molecular sciences | 2018 |
A novel miR17 /protein tyrosine phosphatase-oc/EphA4 regulatory axis of osteoclast activity
KH Lau, MH Sheng |
Archives of Biochemistry and Biophysics | 2018 |
Selective inhibition of Src family kinases by SU6656 increases bone mass by uncoupling bone formation from resorption in mice
C Thouverey, S Ferrari, J Caverzasio |
Bone | 2018 |
Raddeanin A suppresses breast cancer-associated osteolysis through inhibiting osteoclasts and breast cancer cells
Q Wang, J Mo, C Zhao, K Huang, M Feng, W He, J Wang, S Chen, Z Xie, J Ma, S Fan |
Cell Death and Disease | 2018 |
Myosins in Osteoclast Formation and Function
B Lee |
Biomolecules | 2018 |
Identification of N-(5-(phenoxymethyl)-1,3,4-thiadiazol-2-yl)acetamide derivatives as novel protein tyrosine phosphatase epsilon inhibitors exhibiting anti-osteoclastic activity
B Ku, HY Yun, KW Lee, HC Shin, SR Lee, CH Kim, H Park, KY Yi, CH Lee, SJ Kim |
Bioorganic & Medicinal Chemistry | 2018 |
Bone-Fracture-Targeted Dasatinib-Oligoaspartic Acid Conjugate Potently Accelerates Fracture Repair
M Wang, S Park, Y Nam, J Nielsen, SA Low, M Srinivasarao, PS Low |
Bioconjugate Chemistry | 2018 |
The Sealing Zone in Osteoclasts: A Self-Organized Structure on the Bone.
Takito J, Inoue S, Nakamura M |
International journal of molecular sciences | 2018 |
RNF146 is an Osteoclastogenic Switch Regulated by RANK Ligand
Yoshinori Matsumoto, Jose La Rose, Oliver A. Kent, Melissa Lim, Adele Changoor, Lucia Zhang, Yaryna Storozhuk, Xiaohong Mao, Marc Grynpas, Feng Cong, Robert Rottapel |
Journal of Clinical Investigation | 2017 |
Protein kinase N3 promotes bone resorption by osteoclasts in response to Wnt5a-Ror2 signaling
S Uehara, N Udagawa, H Mukai, A Ishihara, K Maeda, T Yamashita, K Murakami, M Nishita, T Nakamura, S Kato, Y Minami, N Takahashi, Y Kobayashi |
Science signaling | 2017 |
RON kinase: A target for treatment of cancer-induced bone destruction and osteoporosis
K Andrade, J Fornetti, L Zhao, SC Miller, RL Randall, N Anderson, SE Waltz, M McHale, AL Welm |
Science Translational Medicine | 2017 |
The Biology of Bone Metastasis
M Esposito, T Guise, Y Kang |
Cold Spring Harbor Perspectives in Medicine | 2017 |
The Actin-Binding Protein PPP1r18 Regulates Maturation, Actin Organization, and Bone Resorption Activity of Osteoclasts
T Matsubara, S Kokabu, C Nakatomi, M Kinbara, T Maeda, M Yoshizawa, H Yasuda, T Takano-Yamamoto, R Baron, E Jimi |
Molecular and cellular biology | 2017 |
Small non-coding RNAs-based bone regulation and targeting therapeutic strategies
Y Yang, S Fang |
Molecular and Cellular Endocrinology | 2017 |
Histochemical assessment for osteoblastic activity coupled with dysfunctional osteoclasts in c-src deficient mice
H TORAY, T HASEGAWA, N SAKAGAMI, E TSUCHIYA, A KUDO, S ZHAO, Y MORITANI, M ABE, T YOSHIDA, T YAMAMOTO, T YAMAMOTO, K ODA, N UDAGAWA, PH de FREITAS, M LI |
Biomedical Research | 2017 |
Regulation of osteoclast differentiation and actin ring formation by the cytolinker protein plectin
T Matsubara, M Kinbara, T Maeda, M Yoshizawa, S Kokabu, TT Yamamoto |
Biochemical and Biophysical Research Communications | 2017 |
Clinical Aspects of Natural and Added Phosphorus in Foods
OM Gutiérrez, K Kalantar-Zadeh, R Mehrotra |
Clinical Aspects of Natural and Added Phosphorus in Foods | 2017 |
Promotion of Tumor Invasion by Tumor-Associated Macrophages: The Role of CSF-1-Activated Phosphatidylinositol 3 Kinase and Src Family Kinase Motility Signaling
A Dwyer, E Greenland, F Pixley |
Cancers | 2017 |
Symmetrical retrograde actin flow in the actin fusion structure is involved in osteoclast fusion
J Takito, H Otsuka, S Inoue, T Kawashima, M Nakamura |
Biology Open | 2017 |
Expression of typical osteoclast markers by PBMCs after PEG-induced fusion as a model for studying osteoclast differentiation
LM Castillo, CA Guerrero, O Acosta |
Journal Of Molecular Histology | 2017 |
Targeted Agents in Preclinical and Early Clinical Development for the Treatment of Cancer Bone Metastases
T Hiraga |
Expert Opinion on Investigational Drugs | 2016 |
Proteomic approaches to study osteoclast biology
S Segeletz, B Hoflack |
PROTEOMICS | 2016 |
Role of miR-222-3p in c-Src-Mediated Regulation of Osteoclastogenesis
S Takigawa, A Chen, Q Wan, S Na, A Sudo, H Yokota, K Hamamura |
International journal of molecular sciences | 2016 |
Notch2 signaling promotes osteoclast resorption via activation of PYK2
WJ Jin, B Kim, JW Kim, HH Kim, H Ha, ZH Lee |
Cellular Signalling | 2016 |
Sanguiin H-6, a constituent of Rubus parvifolius L., inhibits receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis and bone resorption in vitro and prevents tumor necrosis factor-α-induced osteoclast formation in vivo
E Sakai, Y Aoki, M Yoshimatsu, K Nishishita, M Iwatake, Y Fukuma, K Okamoto, T Tanaka, T Tsukuba |
Phytomedicine | 2016 |
Effects of Src-kinase inhibition in cancer-induced bone pain
MD Felice, D Lambert, I Holen, KJ Escott, D Andrew |
Molecular Pain | 2016 |
Src family kinase expression and subcellular localization in macrophages: implications for their role in CSF-1-induced macrophage migration
AR Dwyer, KA Mouchemore, JH Steer, AJ Sunderland, NG Sampaio, EL Greenland, DA Joyce, FJ Pixley |
Journal of leukocyte biology | 2016 |
Role of RANKL in the regulation of NFATc1 and c-Src mRNA expression in osteoclast-like cells
J Fu, YD Tao, J Chen, Y Zhang, J He |
Molecular medicine reports | 2016 |
Glycoprotein130 (Gp130)/interleukin-6 (IL-6) signalling in osteoclasts promotes bone formation in periosteal and trabecular bone
RW Johnson, NE McGregor, HJ Brennan, B Crimeen-Irwin, IJ Poulton, TJ Martin, NA Sims |
Bone | 2015 |
Src inhibitor reduces permeability without disturbing vascularization and prevents bone destruction in steroid-associated osteonecrotic lesions in rabbits
YX He, J Liu, B Guo, YX Wang, X Pan, D Li, T Tang, Y Chen, S Peng, Z Bian, Z Liang, BT Zhang, A Lu, G Zhang |
Scientific Reports | 2015 |
Blockage of Src by Specific siRNA as a Novel Therapeutic Strategy to Prevent Destructive Repair in Steroid-Associated Osteonecrosis in Rabbits: SRC BLOCKAGE PREVENTS DESTRUCTIVE REPAIR IN SAON
L Zheng, H Cao, S Chen, T Tang, W Fu, L Huang, DH Chow, Y Wang, JF Griffith, W He, H Zhou, D Zhao, G Zhang, X Wang, L Qin |
Journal of Bone and Mineral Research | 2015 |
Stauntonia hexaphylla (Lardizabalaceae) leaf methanol extract inhibits osteoclastogenesis and bone resorption activity via proteasome-mediated degradation of c-Fos protein and suppression of NFATc1 expression
YH Cheon, JM Baek, SH Park, SJ Ahn, MS Lee, J Oh, JY Kim |
BMC complementary and alternative medicine | 2015 |
Src enhances osteogenic differentiation through phosphorylation of Osterix
YH Choi, YH Han, SH Lee, H Cheong, KH Chun, CY Yeo, KY Lee |
Molecular and Cellular Endocrinology | 2015 |
Histochemical evidence of zoledronate inhibiting c-src expression and interfering with CD44/OPN-mediated osteoclast adhesion in the tibiae of mice
H Liu, J Cui, J Sun, J Du, W Feng, B Sun, J Li, X Han, B Liu, Yimin, K Oda, N Amizuka, M Li |
Journal Of Molecular Histology | 2015 |
Cancer-targeted therapies and radiopharmaceuticals
TD Rachner, F Jakob, LC Hofbauer |
BoneKEy Reports | 2015 |
Macrophages: Development and Tissue Specialization
C Varol, A Mildner, S Jung |
Annual Review of Immunology | 2015 |
Biology of the RANKL–RANK–OPG System in Immunity, Bone, and Beyond
MC Walsh, Y Choi |
Frontiers in immunology | 2014 |
SRC kinase inhibition with saracatinib limits the development of osteolytic bone disease in multiple myeloma
R Heusschen, J Muller, M Binsfeld, C Marty, E Plougonven, S Dubois, N Mahli, K Moermans, G Carmeliet, A Léonard, F Baron, Y Beguin, E Menu, M Cohen-Solal, J Caers |
Oncotarget | 2014 |
Regulation of Osteoclast Multinucleation by the Actin Cytoskeleton Signaling Network: ACTIN CYTOSKELETON IN OSTEOCLAST FUSION
J Takito, H Otsuka, N Yanagisawa, H Arai, M Shiga, M Inoue, N Nonaka, M Nakamura |
Journal of Cellular Physiology | 2014 |
The Roles of Small GTPases in Osteoclast Biology
MJ Oursler |
Orthopedic & Muscular System | 2014 |
Dissecting the role of bone marrow stromal cells on bone metastases
D Buenrostro, SI Park, JA Sterling |
BioMed Research International | 2014 |
Osteopetrosis in TAK1-deficient mice owing to defective NF-κB and NOTCH signaling
G Swarnkar, K Karuppaiah, G Mbalaviele, TH Chen, Y Abu-Amer |
Proceedings of the National Academy of Sciences | 2014 |
Advances in mechanisms of resistance to aromatase inhibitors
S Chumsri, A Schech, C Chakkabat, G Sabnis, A Brodie |
Expert Review of Anticancer Therapy | 2014 |
Potential anti-osteoporotic activity of low-molecular weight hyaluronan by attenuation of osteoclast cell differentiation and function in vitro
CW Lee, JY Seo, J Choi, J Lee, JW Park, JY Lee, KY Hwang, YS Park, YI Park |
Biochemical and Biophysical Research Communications | 2014 |
The Dectin 1 Agonist Curdlan Regulates Osteoclastogenesis by Inhibiting Nuclear Factor of Activated T cells Cytoplasmic 1 (NFATc1) through Syk Kinase
T Yamasaki, W Ariyoshi, T Okinaga, Y Adachi, R Hosokawa, S Mochizuki, K Sakurai, T Nishihara |
The Journal of biological chemistry | 2014 |
Reference Module in Biomedical Sciences
DL Sackett, RB Haynes |
2014 | |
Reactive oxygen species induce the association of SHP-1 with c-Src and the oxidation of both to enhance osteoclast survival
K Ke, OJ Sul, EK Choi, AM Safdar, ES Kim, HS Choi |
American journal of physiology. Endocrinology and metabolism | 2014 |
The RhoGAP Activity of Myosin IXB Is Critical for Osteoclast Podosome Patterning, Motility, and Resorptive Capacity
BK McMichael, KF Scherer, NC Franklin, BS Lee, PJ Marie |
PloS one | 2014 |
Mechanical Loading in Osteocytes Induces Formation of a Src/Pyk2/MBD2 Complex That Suppresses Anabolic Gene Expression
JM Hum, RN Day, JP Bidwell, Y Wang, FM Pavalko, ND Leipzig |
PloS one | 2014 |
The Role of Inflammatory Cytokines, the RANKL/OPG Axis, and the Immunoskeletal Interface in Physiological Bone Turnover and Osteoporosis
MN Weitzmann |
Scientifica | 2013 |
Postmenopausal osteoporosis: the role of immune system cells
MF Faienza, A Ventura, F Marzano, L Cavallo |
Clinical & developmental immunology | 2013 |
Loss of protein kinase C-δ protects against LPS-induced osteolysis owing to an intrinsic defect in osteoclastic bone resorption
EC Khor, T Abel, J Tickner, SM Chim, C Wang, T Cheng, B Ng, PY Ng, DA Teguh, J Kenny, X Yang, H Chen, KI Nakayama, K Nakayama, N Pavlos, MH Zheng, J Xu |
PloS one | 2013 |
Regulation of osteoclasts by membrane-derived lipid mediators
T Oikawa, Y Kuroda, K Matsuo |
Cellular and Molecular Life Sciences | 2013 |
Advances in osteoclast biology reveal potential new drug targets and new roles for osteoclasts
BF Boyce |
Journal of Bone and Mineral Research | 2013 |
Hck contributes to bone homeostasis by controlling the recruitment of osteoclast precursors
C Vérollet, A Gallois, R Dacquin, C Lastrucci, SN Pandruvada, N Ortega, R Poincloux, A Behar, C Cougoule, C Lowell, TA Saati, P Jurdic, I Maridonneau-Parini |
The FASEB Journal | 2013 |
Treatment options in castration-resistant prostate cancer: Current therapies and emerging docetaxel-based regimens☆
F Saad, K Miller |
Urologic Oncology: Seminars and Original Investigations | 2013 |
p130Cas, Crk-Associated Substrate, Plays Important Roles in Osteoclastic Bone Resorption: P130CAS REGULATES OSTEOCLASTIC BONE RESORPTION
Y Nagai, K Osawa, H Fukushima, Y Tamura, K Aoki, K Ohya, H Yasuda, H Hikiji, M Takahashi, Y Seta, S Seo, M Kurokawa, S Kato, H Honda, I Nakamura, K Maki, E Jimi |
Journal of Bone and Mineral Research | 2013 |
Loss of Protein Kinase C-δ Protects against LPS-Induced Osteolysis Owing to an Intrinsic Defect in Osteoclastic Bone Resorption
EC Khor, T Abel, J Tickner, SM Chim, C Wang, T Cheng, B Ng, PY Ng, DA Teguh, J Kenny, X Yang, H Chen, KI Nakayama, K Nakayama, N Pavlos, MH Zheng, J Xu, Y Komarova |
PloS one | 2013 |
Molecular Mechanism and Targeted Therapy Options of Triple-Negative (ER, PgR, HER-2/neu) Breast Cancer: Review
Kandula |
World Journal of Oncology | 2013 |
Biology and Regulation of Blood-Tissue Barriers
CY Cheng |
2013 | |
Protein Tyrosine Phosphatase Control of Metabolism
KK Bence |
2013 | |
Regulation of bone mass and osteoclast function depend on the F-actin modulator SWAP-70
AI Garbe, A Roscher, C Schüler, AH Lutter, M Glösmann, R Bernhardt, M Chopin, U Hempel, LC Hofbauer, S Rammelt, M Egerbacher, RG Erben, R Jessberger |
Journal of Bone and Mineral Research | 2012 |
PSTPIP2 deficiency in mice causes osteopenia and increased differentiation of multipotent myeloid precursors into osteoclasts
V Chitu, V Nacu, JF Charles, WM Henne, HT McMahon, S Nandi, H Ketchum, R Harris, MC Nakamura, ER Stanley |
Blood | 2012 |
ERK1 Regulates the Hematopoietic Stem Cell Niches
N Saulnier, S Guihard, X Holy, E Decembre, P Jurdic, D Clay, V Feuillet, G Pagès, J Pouysségur, F Porteu, M Gaudry |
PloS one | 2012 |
c-Src Links a RANK/ v 3 Integrin Complex to the Osteoclast Cytoskeleton
T Izawa, W Zou, JC Chappel, JW Ashley, X Feng, SL Teitelbaum |
Molecular and cellular biology | 2012 |
Serum calcium-decreasing factor, caldecrin, inhibits receptor activator of NF-κB ligand (RANKL)-mediated Ca2+ signaling and actin ring formation in mature osteoclasts via suppression of Src signaling pathway
M Tomomura, H Hasegawa, N Suda, H Sakagami, A Tomomura |
The Journal of biological chemistry | 2012 |
Fyn positively regulates the activation of DAP12 and FcRγ-mediated costimulatory signals by RANKL during osteoclastogenesis
HS Kim, DK Kim, AR Kim, SH Mun, SK Lee, JH Kim, YM Kim, WS Choi |
Cellular Signalling | 2012 |
Effects of Src kinase inhibition by saracatinib (AZD0530) on bone turnover in advanced malignancy in a Phase I study
RA Hannon, RD Finkelman, G Clack, RB Iacona, M Rimmer, F Gossiel, J Baselga, R Eastell |
Bone | 2012 |
Fluorescence-based experimental model to evaluate the concomitant effect of drugs on the tumour microenvironment and cancer cells
K Ramasamy, H Khatun, L Macpherson, MP Caley, J Sturge, GJ Mufti, SA Schey, Y Calle |
British Journal of Haematology | 2012 |
Src tyrosine kinase inhibitors in the treatment of lung cancer: rationale and clinical data
SI Rothschild, O Gautschi |
Clinical Investigation | 2012 |
Pediatric Bone
M Bastepe, H Jüppner, RV Thakker |
Pediatric Bone | 2012 |
The osteoclast, bone remodelling and treatment of metabolic bone disease: OSTEOCLASTS AND BONE REMODELLING
BF Boyce, E Rosenberg, AE de Papp, LT Duong |
European Journal of Clinical Investigation | 2012 |
Osteoclast migration, differentiation and function: novel therapeutic targets for rheumatic diseases
J Kikuta, M Ishii |
Rheumatology | 2012 |
ERK1 Regulates the Hematopoietic Stem Cell Niches
N Saulnier, S Guihard, X Holy, E Decembre, P Jurdic, D Clay, V Feuillet, G Pagès, J Pouysségur, F Porteu, M Gaudry, ES Abdelhay |
PloS one | 2012 |
Serum Calcium-decreasing Factor, Caldecrin, Inhibits Receptor Activator of NF-κB Ligand (RANKL)-mediated Ca 2+ Signaling and Actin Ring Formation in Mature Osteoclasts via Suppression of Src Signaling Pathway
M Tomomura, H Hasegawa, N Suda, H Sakagami, A Tomomura |
The Journal of biological chemistry | 2012 |
An osteoclastic protein-tyrosine phosphatase regulates the β 3 -integrin, syk, and shp1 signaling through respective src-dependent phosphorylation in osteoclasts
KH Lau, V Stiffel, M Amoui |
American journal of physiology. Cell physiology | 2012 |
Breast Cancer Metastasis and Drug Resistance
A Ahmad |
2012 | |
C-Src and c-Yes are two unlikely partners of spermatogenesis and their roles in blood-testis barrier dynamics.
Xiao X, Mruk DD, Cheng FL, Cheng CY |
Advances in experimental medicine and biology | 2012 |
3BP2 deficient mice are osteoporotic with impaired osteoblast and osteoclast functions
Noam Levaot, Paul D Simoncic, Ioannis D Dimitriou, Andrew Scotter, Jose La Rose, Adeline HM Ng, Thomas L Willett, Chiachien J Wang, Salima Janmohamed, Marc Grynpas, Ernst Reichenberger, Robert Rottapel |
Journal of Clinical Investigation | 2011 |
Osteoporosis: now and the future
TD Rachner, S Khosla, LC Hofbauer |
Lancet | 2011 |
RNA therapeutics targeting osteoclast-mediated excessive bone resorption
Y Wang, DW Grainger |
Advanced Drug Delivery Reviews | 2011 |
Advances in osteoclast biology: old findings and new insights from mouse models
JR Edwards, GR Mundy |
Nature Reviews Rheumatology | 2011 |
Loss of Tankyrase-Mediated Destruction of 3BP2 Is the Underlying Pathogenic Mechanism of Cherubism
N Levaot, O Voytyuk, I Dimitriou, F Sircoulomb, A Chandrakumar, M Deckert, PM Krzyzanowski, A Scotter, S Gu, S Janmohamed, F Cong, PD Simoncic, Y Ueki, J La Rose, R Rottapel |
Cell | 2011 |
Evidence that the kinase-truncated c-Src regulates NF-κB signaling by targeting NEMO
S Dai, W Abu-Amer, K Karuppaiah, Y Abu-Amer |
Journal of Cellular Biochemistry | 2011 |
Measurement by vertical scanning profilometry of resorption volume and lacunae depth caused by osteoclasts on dentine slices
F Pascaretti-Grizon, G Mabilleau, M Basle, D Chappard |
Journal of Microscopy | 2011 |
Src inhibitors in the treatment of metastatic bone disease: rationale and clinical data
B Boyce, L Xing |
Clinical Investigation | 2011 |
Regulation of osteoclast function
I Nakamura, N Takahashi, E Jimi, N Udagawa, T Suda |
Modern Rheumatology | 2011 |
Signaling networks regulating leukocyte podosome dynamics and function
A Dovas, D Cox |
Cellular Signalling | 2011 |
TAZ is required for the osteogenic and anti-adipogenic activities of kaempferol
MR Byun, H Jeong, SJ Bae, AR Kim, ES Hwang, JH Hong |
Bone | 2011 |
How are osteoclasts induced to resorb bone? : Chambers & Fuller
TJ Chambers, K Fuller |
Annals of the New York Academy of Sciences | 2011 |
Osteoclasts
FP Ross |
Vitamin D | 2011 |
Dasatinib Combined With Docetaxel For Castration-Resistant Prostate Cancer: Results From a Phase 1/2 Study
JC Araujo, P Mathew, AJ Armstrong, EL Braud, E Posadas, M Lonberg, GE Gallick, GC Trudel, P Paliwal, S Agrawal, CJ Logothetis |
Cancer | 2011 |
Mineral Trioxide Aggregate Inhibits Osteoclastic Bone Resorption
D Hashiguchi, H Fukushima, H Yasuda, W Masuda, M Tomikawa, K Morikawa, K Maki, E Jimi |
Journal of dental research | 2011 |
Signaling Pathways in Cancer Pathogenesis and Therapy
DA Frank |
2011 | |
Osteogenic Effects of a Potent Src-over-Abl-Selective Kinase Inhibitor in the Mouse
RJ Murrills, S Fukayama, F Boschelli, JJ Matteo, J Owens, JM Golas, D Patel, G Lane, YB Liu, L Carter, J Jussif, V Spaulding, YD Wang, DH Boschelli, JC McKew, XJ Li, S Lockhead, C Milligan, YP Kharode, V Diesl, Y Bai, M Follettie, FJ Bex, B Komm, PV Bodine |
The Journal of pharmacology and experimental therapeutics | 2011 |
Fyn promotes proliferation, differentiation, survival and function of osteoclast lineage cells
HJ Kim, JT Warren, SY Kim, JC Chappel, CJ DeSelm, FP Ross, W Zou, SL Teitelbaum |
Journal of Cellular Biochemistry | 2010 |
Osteoclasts Lacking Rac2 Have Defective Chemotaxis and Resorptive Activity
T Itokowa, M Zhu, N Troiano, J Bian, T Kawano, K Insogna |
Calcified Tissue International | 2010 |
Emerging Targets in Osteoporosis Disease Modification
JG Allen, C Fotsch, P Babij |
Journal of Medicinal Chemistry | 2010 |
Severe developmental bone phenotype in ClC-7 deficient mice
AV Neutzsky-Wulff, NA Sims, C Supanchart, U Kornak, D Felsenberg, IJ Poulton, TJ Martin, MA Karsdal, K Henriksen |
Developmental Biology | 2010 |
Regulation of Sealing Ring Formation by L-plastin and Cortactin in Osteoclasts*
T Ma, K Sadashivaiah, N Madayiputhiya, MA Chellaiah |
The Journal of biological chemistry | 2010 |
Shedding of RANKL by tumor-associated MT1-MMP activates Src-dependent prostate cancer cell migration
AL Sabbota, HR Kim, X Zhe, R Fridman, RD Bonfil, ML Cher |
Cancer research | 2010 |
c-Src-mediated phosphorylation of thyroid hormone receptor-interacting protein 6 (TRIP6) promotes osteoclast sealing zone formation
BK McMichael, SM Meyer, BS Lee |
The Journal of biological chemistry | 2010 |
3BP2 Adapter protein is required for receptor activator of NFkappaB ligand (RANKL)-induced osteoclast differentiation of RAW264.7 cells
A GuezGuez, V Prod'homme, X Mouska, A Baudot, C Blin-Wakkach, R Rottapel, M Deckert |
The Journal of biological chemistry | 2010 |
GPCR kinase 2 interacting protein 1 (GIT1) regulates osteoclast function and bone mass
P Menon, G Yin, EM Smolock, MJ Zuscik, C Yan, BC Berk |
Journal of Cellular Physiology | 2010 |
Src family kinase/abl inhibitor dasatinib suppresses proliferation and enhances differentiation of osteoblasts
YC Lee, CF Huang, M Murshed, K Chu, JC Araujo, X Ye, B deCrombrugghe, LY Yu-Lee, GE Gallick, SH Lin |
Oncogene | 2010 |
Pharmaceutical Sciences Encyclopedia
D Farkas, RI Shader, LL von Moltke, DJ Greenblatt |
Pharmaceutical Sciences Encyclopedia | 2010 |
Future directions of bone-targeted therapy for metastatic breast cancer
T Onishi, N Hayashi, RL Theriault, GN Hortobagyi, NT Ueno |
Nature Reviews Clinical Oncology | 2010 |
Bone metastases: Molecular mechanisms and novel therapeutic interventions
DJ Papachristou, EK Basdra, AG Papavassiliou |
Medicinal Research Reviews | 2010 |
Src is a major signaling component for CTGF induction by TGF-β1 in osteoblasts
X Zhang, JA Arnott, S Rehman, WG Delong, A Sanjay, FF Safadi, SN Popoff |
Journal of Cellular Physiology | 2010 |
Semisynthetic Src SH2 Domains Demonstrate Altered Phosphopeptide Specificity Induced by Incorporation of Unnatural Lysine Derivatives
S Virdee, D Macmillan, G Waksman |
Chemistry & Biology | 2010 |
Molecular Understanding of Osteoclast Differentiation and Physiology
NK Lee |
Endocrinology and Metabolism | 2010 |
SRC kinase inhibition: Targeting bone metastases and tumor growth in prostate and breast cancer
F Saad, A Lipton |
Cancer Treatment Reviews | 2010 |
Combining Src inhibitors and aromatase inhibitors: A novel strategy for overcoming endocrine resistance and bone loss
S Hiscox, P Barrett-Lee, AC Borley, RI Nicholson |
European Journal of Cancer | 2010 |
Expanding the role of Src and protein-tyrosine phosphatases balance in modulating osteoblast metabolism: Lessons from mice
WF Zambuzzi, R Milani, A Teti |
Biochimie | 2010 |
Effects of the Src kinase inhibitor saracatinib (AZD0530) on bone turnover in healthy men: A randomized, double-blind, placebo-controlled, multiple-ascending-dose phase I trial
RA Hannon, G Clack, M Rimmer, A Swaisland, JA Lockton, RD Finkelman, R Eastell |
Journal of Bone and Mineral Research | 2010 |
Effects of Altered Bone Remodeling and Retention of Cement Lines on Bone Quality in Osteopetrotic Aged c-Src-Deficient Mice
H Nakayama, K Takakuda, HN Matsumoto, A Miyata, O Baba, MJ Tabata, T Ushiki, T Oda, MD McKee, Y Takano |
Calcified Tissue International | 2010 |
Integrins, growth factors, and the osteoclast cytoskeleton
W Zou, SL Teitelbaum |
Annals of the New York Academy of Sciences | 2010 |
ADAM8 Enhances Osteoclast Precursor Fusion and Osteoclast Formation In Vitro and In Vivo
H Ishizuka, V García-Palacios, G Lu, MA Subler, H Zhang, CS Boykin, SJ Choi, L Zhao, K Patrene, DL Galson, HC Blair, TM Hadi, JJ Windle, N Kurihara, GD Roodman |
Journal of Bone and Mineral Research | 2010 |
Fundamentals of Osteoporosis
AM Parfitt |
Fundamentals of Osteoporosis | 2010 |
The tyrosine kinase inhibitor dasatinib dysregulates bone remodeling through inhibition of osteoclasts in vivo
K Vandyke, AL Dewar, P Diamond, S Fitter, CG Schultz, NA Sims, AC Zannettino |
Journal of Bone and Mineral Research | 2010 |
Histological and Histochemical Analyses of Cell-mediated Resorption of Anorganic Bovine Bone Matrix at the Site of Sinus Floor Augmentation in Humans
H Tamaki, H Nakayama, Y Takano |
Journal of Oral Biosciences | 2010 |
Dasatinib: a potent SRC inhibitor in clinical development for the treatment of solid tumors
J Araujo, C Logothetis |
Cancer Treatment Reviews | 2010 |
Src kinase inhibitors: an emerging therapeutic treatment option for prostate cancer
J Edwards |
Expert Opinion on Investigational Drugs | 2010 |
Regulation of Sealing Ring Formation by L-plastin and Cortactin in Osteoclasts
T Ma, K Sadashivaiah, MA Chellaiah |
The Journal of biological chemistry | 2010 |
3BP2 Adapter Protein Is Required for Receptor Activator of NFκB Ligand (RANKL)-induced Osteoclast Differentiation of RAW264.7 Cells
A GuezGuez, V Prod'homme, X Mouska, A Baudot, C Blin-Wakkach, R Rottapel, M Deckert |
The Journal of biological chemistry | 2010 |
Conformational Determinants of Phosphotyrosine Peptides Complexed with the Src SH2 Domain
J Nachman, G Gish, C Virag, T Pawson, R Pomès, E Pai, B Kobe |
PloS one | 2010 |
Bone Is Not Essential for Osteoclast Activation
K Fuller, JL Ross, KA Szewczyk, R Moss, TJ Chambers, M Klymkowsky |
PloS one | 2010 |
The Src family kinase, Lyn, suppresses osteoclastogenesis in vitro and in vivo
HJ Kim, K Zhang, L Zhang, FP Ross, SL Teitelbaum, R Faccio |
Proceedings of the National Academy of Sciences | 2009 |
Role of protein-tyrosine phosphatases in regulation of osteoclastic activity
MH Sheng, KH Lau |
Cellular and molecular life sciences : CMLS | 2009 |
Inhibition of the classical NF-κB pathway prevents osteoclast bone-resorbing activity
NS Soysa, N Alles, H Shimokawa, E Jimi, K Aoki, K Ohya |
Journal of Bone and Mineral Metabolism | 2009 |
Src as a therapeutic target in men with prostate cancer and bone metastases
F Saad |
BJU International | 2009 |
Targeting Src signaling in metastatic bone disease
J Araujo, C Logothetis |
International Journal of Cancer | 2009 |
Negative feedback control of osteoclast formation through ubiquitin-mediated down-regulation of NFATc1
JH Kim, K Kim, HM Jin, I Song, BU Youn, SH Lee, Y Choi, N Kim |
The Journal of biological chemistry | 2009 |
Cadmium osteotoxicity in experimental animals: mechanisms and relationship to human exposures
MH Bhattacharyya |
Toxicology and Applied Pharmacology | 2009 |
Activation of Src kinase by protein-tyrosine phosphatase-PEST in osteoclasts: Comparative analysis of the effects of bisphosphonate and protein-tyrosine phosphatase inhibitor on Src activation in vitro
MA Chellaiah, MD Schaller |
Journal of Cellular Physiology | 2009 |
Overexpression of cathepsin K accelerates the resorption cycle and osteoblast differentiation in vitro
J Morko, R Kiviranta, MT Mulari, KK Ivaska, HK Väänänen, E Vuorio, T Laitala-Leinonen |
Bone | 2009 |
Signaling Networks that Control the Lineage Commitment and Differentiation of Bone Cells
CS Soltanoff, S Yang, W Chen, YP Li |
Critical reviews in eukaryotic gene expression | 2009 |
Dasatinib inhibits both osteoclast activation and prostate cancer PC-3-cell-induced osteoclast formation
JC Araujo, A Poblenz, P Corn, NU Parikh, MW Starbuck, JT Thompson, F Lee, CJ Logothetis, BG Darnay |
Cancer biology & therapy | 2009 |
Dasatinib inhibits both osteoclast activation and prostate cancer PC-3 cell-induced osteoclast formation
JC Araujo, A Poblenz, PG Corn, NU Parikh, MW Starbuck, JT Thompson, F Lee, CJ Logothetis, BG Darnay |
Cancer biology & therapy | 2009 |
Inhibitory regulation of osteoclast bone resorption by signal regulatory protein α
EM van Beek, TJ de Vries, L Mulder, T Schoenmaker, KA Hoeben, T Matozaki, GE Langenbach, G Kraal, V Everts, TK van den Berg |
The FASEB Journal | 2009 |
The Novel Adaptor Protein Tks4 (SH3PXD2B) Is Required for Functional Podosome Formation
MD Buschman, PA Bromann, P Cejudo-Martin, F Wen, I Pass, SA Courtneidge, J Brugge |
Molecular biology of the cell | 2009 |
CD45 regulates retention, motility, and numbers of hematopoietic progenitors, and affects osteoclast remodeling of metaphyseal trabecules
S Shivtiel, O Kollet, K Lapid, A Schajnovitz, P Goichberg, A Kalinkovich, E Shezen, M Tesio, N Netzer, I Petit, A Sharir, T Lapidot |
Journal of Experimental Medicine | 2008 |
Osteoimmunology: interactions of the bone and immune system
J Lorenzo, M Horowitz, Y Choi |
Endocrine reviews | 2008 |
The Osteoclast: Friend or Foe?
DV Novack, SL Teitelbaum |
Annual Review of Pathology: Mechanisms of Disease | 2008 |
VEGF-C, a lymphatic growth factor, is a RANKL target gene in osteoclasts that enhances osteoclastic bone resorption through an autocrine mechanism
Q Zhang, R Guo, Y Lu, L Zhao, Q Zhou, EM Schwarz, J Huang, D Chen, ZG Jin, BF Boyce, L Xing |
The Journal of biological chemistry | 2008 |
Phospholipase Cγ2 Modulates Integrin Signaling in the Osteoclast by Affecting the Localization and Activation of Src Kinase
H Epple, V Cremasco, K Zhang, D Mao, GD Longmore, R Faccio |
Molecular and cellular biology | 2008 |
HCO3-/Cl- anion exchanger SLC4A2 is required for proper osteoclast differentiation and function
J Wu, LH Glimcher, AO Aliprantis |
Proceedings of the National Academy of Sciences | 2008 |
SAR of Carbon-Linked, 2-Substituted Purines: Synthesis and Characterization of AP23451 as a novel Bone-Targeted Inhibitor of Src Tyrosine Kinase With In Vivo Anti-Resorptive Activity
WC Shakespeare, Y Wang, R Bohacek, T Keenan, R Sundaramoorthi, C Metcalf, A Dilauro, S Roeloffzen, S Liu, J Saltmarsh, G Paramanathan, D Dalgarno, S Narula, S Pradeepan, MR van Schravendijk, J Keats, M Ram, S Liou, S Adams, S Wardwell, J Bogus, J Iuliucci, M Weigele, L Xing, B Boyce, TK Sawyer |
Chemical Biology & Drug Design | 2008 |
Structure, dynamics, and binding thermodynamics of the v-Src SH2 domain: Implications for drug design
JD Taylor, A Ababou, RR Fawaz, CJ Hobbs, MA Williams, JE Ladbury |
Proteins: Structure, Function, and Bioinformatics | 2008 |
The receptor protein tyrosine phosphatase PTP69D antagonizes Abl tyrosine kinase to guide axons in Drosophila
JK Song, E Giniger, CJ Desai |
Mechanisms of Development | 2008 |
Mechanisms of tooth eruption and orthodontic tooth movement
GE Wise, GJ King |
Journal of dental research | 2008 |
Therapeutic concentrations of dasatinib inhibit in vitro osteoclastogenesis
K Vandyke, AL Dewar, AN Farrugia, S Fitter, LB To, TP Hughes, AC Zannettino |
Leukemia | 2008 |
Differential subcellular membrane recruitment of Src may specify its downstream signalling
P Diesbach, T Medts, S Carpentier, L D'Auria, PV der Smissen, A Platek, M Mettlen, A Caplanusi, MF Hove, D Tyteca, PJ Courtoy |
Experimental Cell Research | 2008 |
Targeting Src in breast cancer
RS Finn |
Annals of Oncology | 2008 |
Osteopetrosis: from Animal Models to Human Conditions
B Perdu, W Hul, L Wesenbeeck |
Clinical Reviews in Bone and Mineral Metabolism | 2008 |
Principles of Bone Biology
CJ Rosen, T Niu |
Principles of Bone Biology | 2008 |
An Overview of Bone Cells and their Regulating Factors of Differentiation
AM Mohamed |
The Malaysian Journal of Medical Sciences : MJMS | 2008 |
VEGF-C, a Lymphatic Growth Factor, Is a RANKL Target Gene in Osteoclasts That Enhances Osteoclastic Bone Resorption through an Autocrine Mechanism
Q Zhang, R Guo, Y Lu, L Zhao, Q Zhou, EM Schwarz, J Huang, D Chen, ZG Jin, BF Boyce, L Xing |
The Journal of biological chemistry | 2008 |
Potential Molecular Mechanism for c-Src Kinase-mediated Regulation of Intestinal Cell Migration
S Mathew, SP George, Y Wang, MR Siddiqui, K Srinivasan, L Tan, S Khurana |
The Journal of biological chemistry | 2008 |
Parathyroid hormone mediates bone growth through the regulation of osteoblast proliferation and differentiation
GJ Pettway, JA Meganck, AJ Koh, ET Keller, SA Goldstein, LK McCauley |
Bone | 2007 |
Syk, c-Src, the alphavbeta3 integrin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorption
W Zou, H Kitaura, J Reeve, F Long, VL Tybulewicz, SJ Shattil, MH Ginsberg, FP Ross, SL Teitelbaum |
The Journal of Cell Biology | 2007 |
Negative autoregulation of RANKL and c-Src signaling in osteoclasts
K Yogo, N Ishida-Kitagawa, T Takeya |
Journal of Bone and Mineral Metabolism | 2007 |
Liječenje Osteoporoze
P Šimić, Z Giljević, V Šimunić, S Vukičević, M Koršić |
Archives of Industrial Hygiene and Toxicology | 2007 |
Emerging pharmacologic therapies for osteoporosis
A Grey |
Expert Opinion on Emerging Drugs | 2007 |
Osteoimmunology
M Rauner, W Sipos, P Pietschmann |
International Archives of Allergy and Immunology | 2007 |
A transmembrane osteoclastic protein-tyrosine phosphatase regulates osteoclast activity in part by promoting osteoclast survival through c-Src-dependent activation of NFkappaB and JNK2
M Amoui, MH Sheng, ST Chen, DJ Baylink, KH Lau |
Archives of Biochemistry and Biophysics | 2007 |
Comprehensive Medicinal Chemistry II
E Littler, XX Zhou |
Comprehensive Medicinal Chemistry II | 2007 |
Phosphorylation of a Wiscott-Aldrich Syndrome Protein-associated Signal Complex Is Critical in Osteoclast Bone Resorption
MA Chellaiah, D Kuppuswamy, L Lasky, S Linder |
The Journal of biological chemistry | 2007 |
Diverse effects of c-src deficiency on molar tooth development and eruption in mice
A Miyata, O Baba, T Oda, I Ishikawa, Y Takano |
Archives of Histology and Cytology | 2007 |
The role of Src in prostate cancer
K Fizazi |
Annals of Oncology | 2007 |
Targeted Interference with Signal Transduction Events
B Groner |
2007 | |
Identification of a Novel Pyrazolo[3,4- d ]pyrimidine Able To Inhibit Cell Proliferation of a Human Osteogenic Sarcoma in Vitro and in a Xenograft Model in Mice
F Manetti, A Santucci, GA Locatelli, G Maga, A Spreafico, T Serchi, M Orlandini, G Bernardini, NP Caradonna, A Spallarossa, C Brullo, S Schenone, O Bruno, A Ranise, F Bondavalli, O Hoffmann, M Bologna, A Angelucci, M Botta |
Journal of Medicinal Chemistry | 2007 |
Future Anti-Catabolic Therapeutic Targets in Bone Disease
BF Boyce |
Annals of the New York Academy of Sciences | 2006 |
An osteoclastic protein-tyrosine phosphatase is a potential positive regulator of the c-Src protein-tyrosine kinase activity: A mediator of osteoclast activity
KH Lau, LW Wu, MH Sheng, M Amoui, SM Suhr, DJ Baylink |
Journal of Cellular Biochemistry | 2006 |
Regulation of osteoclast function and bone mass by RAGE
Z Zhou, D Immel, CX Xi, A Bierhaus, X Feng, L Mei, P Nawroth, DM Stern, WC Xiong |
Journal of Experimental Medicine | 2006 |
Molecular regulation of osteoclast activity
A Bruzzaniti, R Baron |
Reviews in Endocrine and Metabolic Disorders | 2006 |
Critical role of cortactin in actin ring formation and osteoclastic bone resorption
T Matsubara, A Myoui, F Ikeda, K Hata, H Yoshikawa, R Nishimura, T Yoneda |
Journal of Bone and Mineral Metabolism | 2006 |
Herbal formulation, Yukmi-jihang-tang-Jahage, regulates bone resorption by inhibition of phosphorylation mediated by tyrosine kinase Src and cyclooxygenase expression
UH Jin, DI Kim, TK Lee, DN Lee, JK Kim, IS Lee, CH Kim |
Journal of Ethnopharmacology | 2006 |
Regulation of Osteoclast Differentiation (Identification of osteoclast and macrophage fusion protein; DC-STAMP)
T Miyamoto |
Journal of Korean Endocrine Society | 2006 |
c-Src control of chloride channel support for osteoclast HCl transport and bone resorption
JC Edwards, C Cohen, W Xu, PH Schlesinger |
The Journal of biological chemistry | 2006 |
Caspase-2 deficiency enhances aging-related traits in mice
Y Zhang, SS Padalecki, AR Chaudhuri, ED Waal, BA Goins, B Grubbs, Y Ikeno, A Richardson, GR Mundy, B Herman |
Mechanisms of Ageing and Development | 2006 |
Osteoclasts play a part in pain due to the inflammation adjacent to bone
M Nagae, T Hiraga, H Wakabayashi, L Wang, K Iwata, T Yoneda |
Bone | 2006 |
Involvement of the SH3 domain in Ca2+-mediated regulation of Src family kinases
AN Monteiro |
Biochimie | 2006 |
Preparation of Low Density Lipoprotein from Large Apheresis Cartridges for Induction of Cell Death in Saos2 Osteoblasts
BY Klein, Z Kerem, N Rojansky |
Therapeutic Apheresis and Dialysis | 2006 |
LDL induces Saos2 osteoblasts death via Akt pathways responsive to a neutral sphingomyelinase inhibitor
BY Klein, Z Kerem, N Rojansky |
Journal of Cellular Biochemistry | 2006 |
Src Triggers Circular Ruffling and Macropinocytosis at the Apical Surface of Polarized MDCK Cells
M Mettlen, A Platek, PV der Smissen, S Carpentier, M Amyere, L Lanzetti, P Diesbach, D Tyteca, PJ Courtoy |
Traffic | 2006 |
Matricellular proteins: Extracellular modulators of bone development, remodeling, and regeneration
AI Alford, KD Hankenson |
Bone | 2006 |
Structural features of incremental line-like striations in mandibular condylar cartilage of c-src-deficient mice
S Shibata, T Oda, T Abe, Y Yamashita, Y Takano |
Archives of Oral Biology | 2006 |
Dynamics of Bone and Cartilage Metabolism
JE Mulder, CA Kulak, E Shane |
Dynamics of Bone and Cartilage Metabolism | 2006 |
Review of the Effects of Anti-Angiogenic Compounds on the Epiphyseal Growth Plate
AP Hall, FR Westwood, PF Wadsworth |
Toxicologic pathology | 2006 |
Osteoclasts and Integrins
SL Teitelbaum |
Annals of the New York Academy of Sciences | 2006 |
Src Homology 2 (SH2)-Containing 5′-Inositol Phosphatase Localizes to Podosomes, and the SH2 Domain Is Implicated in the Attenuation of Bone Resorption in Osteoclasts
K Yogo, M Mizutamari, K Mishima, H Takenouchi, N Ishida-Kitagawa, T Sasaki, T Takeya |
Endocrinology | 2006 |
Activation of NFAT Signal In Vivo Leads to Osteopenia Associated with Increased Osteoclastogenesis and Bone-Resorbing Activity
F Ikeda, R Nishimura, T Matsubara, K Hata, SV Reddy, T Yoneda |
Journal of immunology (Baltimore, Md. : 1950) | 2006 |
Paget disease of bone
GD Roodman, JJ Windle |
Journal of Clinical Investigation | 2005 |
Osteoclasts; culprits in inflammatory osteolysis
SL Teitelbaum |
Arthritis Research & Therapy | 2005 |
Roles for NF-κB and c-Fos in osteoclasts
BF Boyce, T Yamashita, Z Yao, Q Zhang, F Li, L Xing |
Journal of Bone and Mineral Metabolism | 2005 |
DC-STAMP is essential for cell–cell fusion in osteoclasts and foreign body giant cells
M Yagi, T Miyamoto, Y Sawatani, K Iwamoto, N Hosogane, N Fujita, K Morita, K Ninomiya, T Suzuki, K Miyamoto, Y Oike, M Takeya, Y Toyama, T Suda |
Journal of Experimental Medicine | 2005 |
Recent advances in the discovery of Src kinase inhibitors
K Parang, G Sun |
Expert Opinion on Therapeutic Patents | 2005 |
alphavbeta3 and macrophage colony-stimulating factor: partners in osteoclast biology
FP Ross, SL Teitelbaum |
Immunological Reviews | 2005 |
Emerging and potential therapies for osteoporosis
A Grey, IR Reid |
Expert Opinion on Investigational Drugs | 2005 |
Regulation of apoptosis in osteoclasts and osteoblastic cells
L Xing, BF Boyce |
Biochemical and Biophysical Research Communications | 2005 |
The role(s) of Src kinase and Cbl proteins in the regulation of osteoclast differentiation and function
WC Horne, A Sanjay, A Bruzzaniti, R Baron |
Immunological Reviews | 2005 |
CSF-1 Induces fos Gene Transcription and Activates the Transcription Factor Elk-1 in Mature Osteoclasts
GQ Yao, T Itokawa, I Paliwal, K Insogna |
Calcified Tissue International | 2005 |
The role of macrophages in osteolysis of total joint replacement
E Ingham, J Fisher |
Biomaterials | 2005 |
SC-19220, Antagonist of Prostaglandin E2 Receptor EP1, Inhibits Osteoclastogenesis by RANKL
T Tsujisawa, H Inoue, T Nishihara |
Journal of Bone and Mineral Research | 2005 |
The glutamatergic system outside the CNS and in cancer biology
N Kalariti, N Pissimissis, M Koutsilieris |
Expert Opinion on Investigational Drugs | 2005 |
A RANKL-Inducible Gene Znf216 in Osteoclast Differentiation
A Hishiya, K Ikeda, K Watanabe |
Journal of Receptors and Signal Transduction | 2005 |
Src64 is involved in fusome development and karyosome formation during Drosophila oogenesis
I Djagaeva, S Doronkin, SK Beckendorf |
Developmental Biology | 2005 |
Intracellular signal transduction pathways: good therapeutic targets for joint destruction in rheumatoid arthritis
S Tanaka |
Modern Rheumatology | 2005 |
c-Yes response to growth factor activation: Mini Review
DA Clump, DA Clump, IH Qazi, DA Clump, IH Qazi, M Sudol, DC Flynn |
Growth Factors | 2005 |
Physical and Functional Association of c-Src and Adhesion and Degranulation Promoting Adaptor Protein (ADAP) in Osteoclastogenesis in Vitro
S Koga, K Yogo, K Yoshikawa, H Samori, M Goto, T Uchida, N Ishida, T Takeya |
The Journal of biological chemistry | 2005 |
Bone Resorption
F Bronner, MC Farach-Carson, J Rubin |
2005 | |
Absence of Fyn and Src Causes a Reeler-Like Phenotype
G Kuo |
The Journal of neuroscience : the official journal of the Society for Neuroscience | 2005 |
Proteomics and Protein-Protein Interactions
G Waksman |
2005 | |
Bacterial Protein Toxins: Role in the Interference with Cell Growth Regulation
AJ Lax |
2005 | |
Systemic tumor necrosis factor alpha mediates an increase in peripheral CD11bhigh osteoclast precursors in tumor necrosis factor alpha-transgenic mice
P Li, EM Schwarz, RJ O'Keefe, L Ma, RJ Looney, CT Ritchlin, BF Boyce, L Xing |
Arthritis & Rheumatism | 2004 |
Genetically Modified Animal Models as Tools for Studying Bone and Mineral Metabolism
RA Davey, HE MacLean, JF McManus, DM Findlay, JD Zajac |
Journal of Bone and Mineral Research | 2004 |
Localization of Tec29 to ring canals is mediated by Src64 and PtdIns(3,4,5)P3-dependent mechanisms
N Lu, DJ Guarnieri, MA Simon |
The EMBO Journal | 2004 |
Tyrosine phosphorylation controls Runx2-mediated subnuclear targeting of YAP to repress transcription
SK Zaidi, AJ Sullivan, R Medina, Y Ito, AJ van Wijnen, JL Stein, JB Lian, GS Stein |
The EMBO Journal | 2004 |
Tyrosine phosphatase epsilon is a positive regulator of osteoclast function in vitro and in vivo
R Chiusaroli, H Knobler, C Luxenburg, A Sanjay, S Granot-Attas, Z Tiran, T Miyazaki, A Harmelin, R Baron, A Elson |
Molecular biology of the cell | 2004 |
ATP-phosphopeptide conjugates as inhibitors of Src tyrosine kinases
NH Nam, S Lee, G Ye, G Sun, K Parang |
Bioorganic & Medicinal Chemistry | 2004 |
Induction of mouse c-src in RAW264 cells is dependent on AP-1 and NF-κB and important for progression to multinucleated cell formation
N Kumagai, K Ohno, R Tameshige, M Hoshijima, K Yogo, N Ishida, T Takeya |
Biochemical and Biophysical Research Communications | 2004 |
Cancer metastasis therapeutic targets and drug discovery: emerging small-molecule protein kinase inhibitors
TK Sawyer |
Expert Opinion on Investigational Drugs | 2004 |
Reduction of c-Src activity by substituted 5,7-diphenyl-pyrrolo[2,3-d]-pyrimidines induces osteoclast apoptosis in vivo and in vitro. Involvement of ERK1/2 pathway
I Recchia, N Rucci, A Funari, S Migliaccio, A Taranta, M Longo, M Kneissel, M Šuša, D Fabbro, A Teti |
Bone | 2004 |
Physiological role of mGSTA4-4, a glutathione S-transferase metabolizing 4-hydroxynonenal: generation and analysis of mGsta4 null mouse
MR Engle, SP Singh, PJ Czernik, D Gaddy, DC Montague, JD Ceci, Y Yang, S Awasthi, YC Awasthi, P Zimniak |
Toxicology and Applied Pharmacology | 2004 |
SH3P2 in complex with Cbl and Src
I Szymkiewicz, O Destaing, P Jurdic, I Dikic |
FEBS Letters | 2004 |
Highlights from: The 2nd Annual Future of Supportive Therapy in Oncology; St. Kitts, West Indies
N Price, GK Reddy, VK Jain |
Supportive Cancer Therapy | 2004 |
Bone Tissue Engineering
H Donahue, E Vogler, C Siedlecki |
Bone Tissue Engineering | 2004 |
Osteoclastic bone resorption through receptor tyrosine kinase and extracellular signal-regulated kinase signaling in mature osteoclasts
H Kawaguchi, M Katagiri, D Chikazu |
Modern Rheumatology | 2004 |
N ew M olecules in the T umor N ecrosis F actor L igand and R eceptor S uperfamilies with I mportance for P hysiological and P athological B one R esorption
UH Lerner |
Critical Reviews in Oral Biology & Medicine | 2004 |
Hematological defects in the oc/oc mouse, a model of infantile malignant osteopetrosis
C Blin-Wakkach, A Wakkach, PM Sexton, N Rochet, GF Carle |
Leukemia | 2004 |
Bone remodeling: new aspects of a key process that controls skeletal maintenance and repair
P Pogoda, M Priemel, JM Rueger, M Amling |
Osteoporosis International | 2004 |
The Skeleton
EJ Massaro, JM Rogers |
2004 | |
Collagenase cleavage of type I collagen is essential for both basal and parathyroid hormone (PTH)/PTH-related peptide receptor-induced osteoclast activation and has differential effects on discrete bone compartments
R Chiusaroli, A Maier, MC Knight, M Byrne, LM Calvi, R Baron, SM Krane, E Schipani |
Endocrinology | 2003 |
Genetic regulation of osteoclast development and function
SL Teitelbaum, FP Ross |
Nature Reviews Genetics | 2003 |
Regulation of the formation of osteoclastic actin rings by proline-rich tyrosine kinase 2 interacting with gelsolin
Q Wang, Y Xie, QS Du, XJ Wu, X Feng, L Mei, JM McDonald, WC Xiong |
The Journal of Cell Biology | 2003 |
Mesenchymal progenitor self-renewal deficiency leads to age-dependent osteoporosis in Sca-1/Ly-6A null mice
M Bonyadi, SD Waldman, D Liu, JE Aubin, MD Grynpas, WL Stanford |
Proceedings of the National Academy of Sciences | 2003 |
Participation of protein kinase c β in osteoclast differentiation and function
SW Lee, HB Kwak, WJ Chung, H Cheong, HH Kim, ZH Lee |
Bone | 2003 |
Association of natural tooth loss with genetic variation at the SRC locus among elderly women in Japan
H Hirano, Y Ezura, H Yoshida, T Suzuki, T Hosoi, M Emi |
Geriatrics and Gerontology International | 2003 |
Regulation of bone remodeling and emerging breakthrough drugs for osteoporosis and osteolytic bone metastases
BF Boyce, L Xing, W Shakespeare, Y Wang, D Dalgarno, J Iuliucci, T Sawyer |
Kidney International | 2003 |
Biology of the TRANCE axis
MC Walsh, Y Choi |
Cytokine & Growth Factor Reviews | 2003 |
Bone-Targeted pyrido[2,3-d]pyrimidin-7-ones: potent inhibitors of Src tyrosine kinase as novel antiresorptive agents
CB Vu, GP Luke, N Kawahata, WC Shakespeare, Y Wang, R Sundaramoorthi, CA Metcalf, TP Keenan, S Pradeepan, E Corpuz, T Merry, RS Bohacek, DC Dalgarno, SS Narula, MR van Schravendijk, MK Ram, S Adams, S Liou, JA Keats, SM Violette, W Guan, M Weigele, TK Sawyer |
Bioorganic & Medicinal Chemistry Letters | 2003 |
Expression of Either NF-κB p50 or p52 in Osteoclast Precursors Is Required for IL-1-Induced Bone Resorption
L Xing, L Carlson, B Story, Z Tai, P Keng, U Siebenlist, BF Boyce |
Journal of Bone and Mineral Research | 2003 |
RANK-Fc: A therapeutic antagonist for RANK-L in myeloma
EM Sordillo, RN Pearse |
Cancer | 2003 |
Regulation of cytochrome c oxidase activity by c-Src in osteoclasts
T Miyazaki, L Neff, S Tanaka, WC Horne, R Baron |
The Journal of Cell Biology | 2003 |
Membrane Rafts Play a Crucial Role in Receptor Activator of Nuclear Factor κB Signaling and Osteoclast Function
H Ha, HB Kwak, SK Lee, DS Na, CE Rudd, ZH Lee, HH Kim |
The Journal of biological chemistry | 2003 |
Bisphosphonates and metastatic breast carcinoma
A Lipton |
Cancer | 2003 |
Cell death in cultured human Saos2 osteoblasts exposed to low-density lipoprotein
BY Klein, N Rojansky, A Ben-Yehuda, I Abou-Atta, S Abedat, G Friedman |
Journal of Cellular Biochemistry | 2003 |
The SH4-Unique-SH3-SH2 domains dictate specificity in signaling that differentiate c-Yes from c-Src
JM Summy, Y Qian, BH Jiang, A Guappone-Koay, A Gatesman, X Shi, DC Flynn |
Journal of cell science | 2003 |
DIRECTIONS OFDRUGDISCOVERY INOSTEOPOROSIS
GR Mundy |
Annual Review of Medicine | 2002 |
Emerging techniques for the discovery and validation of therapeutic targets for skeletal diseases
CH Cho, ME Nuttall |
Expert Opinion on Therapeutic Targets | 2002 |
Down-Regulation of Osteoclast Differentiation by Daidzein via Caspase 3
CM Rassi, M Lieberherr, G Chaumaz, A Pointillart, G Cournot |
Journal of Bone and Mineral Research | 2002 |
Inhibitory Effect of Carthamus tinctorius L. Seed Extracts on Bone Resorption Mediated by Tyrosine Kinase, COX-2 (cyclooxygenase) and PG (prostaglandin) E 2
TH Yuk, JH Kang, SR Lee, SW Yuk, KG Lee, BY Song, CH Kim, DW Kim, DI Kim, TK Lee, CH Lee |
The American journal of Chinese medicine | 2002 |
Drosophila Kelch regulates actin organization via Src64-dependent tyrosine phosphorylation
RJ Kelso, AM Hudson, L Cooley |
The Journal of Cell Biology | 2002 |
c-Src-dependent Transcriptional Activation of TFII-I
V Cheriyath, ZP Desgranges, AL Roy |
The Journal of biological chemistry | 2002 |
A RANK/TRAF6-dependent Signal Transduction Pathway Is Essential for Osteoclast Cytoskeletal Organization and Resorptive Function
AP Armstrong, ME Tometsko, M Glaccum, CL Sutherland, D Cosman, WC Dougall |
The Journal of biological chemistry | 2002 |
IL-1 Regulates Cytoskeletal Organization in Osteoclasts Via TNF Receptor-Associated Factor 6/c-Src Complex
I Nakamura, Y Kadono, H Takayanagi, E Jimi, T Miyazaki, H Oda, K Nakamura, S Tanaka, GA Rodan, LT Duong |
Journal of immunology (Baltimore, Md. : 1950) | 2002 |
Receptor Activator of NF-κB Ligand (RANKL) Activates TAK1 Mitogen-Activated Protein Kinase Kinase Kinase through a Signaling Complex Containing RANK, TAB2, and TRAF6
J Mizukami, G Takaesu, H Akatsuka, H Sakurai, J Ninomiya-Tsuji, K Matsumoto, N Sakurai |
Molecular and cellular biology | 2002 |
Principles Governing the Binding of a Class of Non-Peptidic Inhibitors to the SH2 Domain of src Studied by X-ray Analysis
G Lange, D Lesuisse, P Deprez, B Schoot, P Loenze, D Bénard, JP Marquette, P Broto, E Sarubbi, E Mandine |
Journal of Medicinal Chemistry | 2002 |
SAR and X-ray. A New Approach Combining Fragment-Based Screening and Rational Drug Design: Application to the Discovery of Nanomolar Inhibitors of Src SH2
D Lesuisse, G Lange, P Deprez, D Bénard, B Schoot, G Delettre, JP Marquette, P Broto, V Jean-Baptiste, P Bichet, E Sarubbi, E Mandine |
Journal of Medicinal Chemistry | 2002 |
Tissue Inhibitor of Metalloproteinases 1 and 2 Directly Stimulate the Bone-Resorbing Activity of Isolated Mature Osteoclasts
T Sobue, Y Hakeda, Y Kobayashi, H Hayakawa, K Yamashita, T Aoki, M Kumegawa, T Noguchi, T Hayakawa |
Journal of Bone and Mineral Research | 2001 |
Bone-targeted Src SH2 inhibitors block Src cellular activity and osteoclast-mediated resorption
SM Violette, W Guan, C Bartlett, JA Smith, C Bardelay, E Antoine, RJ Rickles, E Mandine, MR Schravendijk, SE Adams, BA Lynch, WC Shakespeare, M Yang, VA Jacobsen, CS Takeuchi, KJ Macek, RS Bohacek, DC Dalgarno, M Weigele, D Lesuisse, TK Sawyer, R Baron |
Bone | 2001 |
Src inhibitors: genomics to therapeutics
T Sawyer, B Boyce, D Dalgarno, J Iuliucci |
Expert Opinion on Investigational Drugs | 2001 |
Antisense Oligodeoxynucleotide Evidence That a Unique Osteoclastic Protein-Tyrosine Phosphatase Is Essential for Osteoclastic Resorption
SM Suhr, S Pamula, DJ Baylink, KH Lau |
Journal of Bone and Mineral Research | 2001 |
Genetic evidence for a role for Src family kinases in TNF family receptor signaling and cell survival
L Xing, AM Venegas, A Chen, L Garrett-Beal, BF Boyce, HE Varmus, PL Schwartzberg |
Genes & development | 2001 |
Convergence of alpha(v)beta(3) integrin- and macrophage colony stimulating factor-mediated signals on phospholipase Cgamma in prefusion osteoclasts
I Nakamura, L Lipfert, GA Rodan, LT Duong |
The Journal of Cell Biology | 2001 |
The Src Signaling Pathway Regulates Osteoclast Lysosomal Enzyme Secretion and Is Rapidly Modulated by Estrogen
D Pascoe, MJ Oursler |
Journal of Bone and Mineral Research | 2001 |
Genistein, a Soybean Isoflavone, Inhibits Inward Rectifier K+ Channels in Rat Osteoclasts
F Okamoto, K Okabe, H Kajiya |
The Japanese Journal of Physiology | 2001 |
Convergence of v 3Integrin-And Macrophage Colony Stimulating Factor-Mediated Signals on Phospholipase C in Prefusion Osteoclasts
I Nakamura, L Lipfert, GA Rodan, LT Duong |
The Journal of Cell Biology | 2001 |
7-Alkyl- and 7-Cycloalkyl-5-aryl-pyrrolo[2,3-d]pyrimidines—potent inhibitors of the tyrosine kinase c-Src
L Widler, J Green, M Missbach, M Šuša, E Altmann |
Bioorganic & Medicinal Chemistry Letters | 2001 |
7-Pyrrolidinyl- and 7-piperidinyl-5-aryl-pyrrolo[2,3-d]pyrimidines—potent inhibitors of the tyrosine kinase c-Src
E Altmann, M Missbach, J Green, M Šuša, HA Wagenknecht, L Widler |
Bioorganic & Medicinal Chemistry Letters | 2001 |
The mouse osteopetrotic grey-lethal mutation induces a defect in osteoclast maturation/function
V Rajapurohitam, N Chalhoub, N Benachenhou, L Neff, R Baron, J Vacher |
Bone | 2001 |
Brain and Bone: Central Regulation of Bone Mass: A New Paradigm in Skeletal Biology
M Haberland, AF Schilling, JM Rueger, M Amling |
The Journal of Bone and Joint Surgery. American volume. | 2001 |
Osteoclast-stimulating Factor Interacts with the Spinal Muscular Atrophy Gene Product to Stimulate Osteoclast Formation
N Kurihara, C Menaa, H Maeda, DJ Haile, SV Reddy |
The Journal of biological chemistry | 2001 |
Phosphatidylinositol 3,4,5-Trisphosphate Directs Association of Src Homology 2-containing Signaling Proteins with Gelsolin
MA Chellaiah, RS Biswas, D Yuen, UM Alvarez, KA Hruska |
The Journal of biological chemistry | 2001 |
UCS15A, a non-kinase inhibitor of Src signal transduction
SV Sharma, C Oneyama, Y Yamashita, H Nakano, K Sugawara, M Hamada, N Kosaka, T Tamaoki |
Oncogene | 2001 |
Noninvasive Assessment of Trabecular Bone Architecture and the Competence of Bone
S Majumdar, BK Bay |
2001 | |
Abnormal localisation and hyperclustering of (alpha)(V)(beta)(3) integrins and associated proteins in Src-deficient or tyrphostin A9-treated osteoclasts
PT Lakkakorpi, I Nakamura, M Young, L Lipfert, GA Rodan, LT Duong |
Journal of cell science | 2001 |
Synthesis and Src Kinase Inhibitory Activity of a Series of 4-Phenylamino-3-quinolinecarbonitriles
DH Boschelli, YD Wang, F Ye, B Wu, N Zhang, M Dutia, DW Powell, A Wissner, K Arndt, JM Weber, F Boschelli |
Journal of Medicinal Chemistry | 2001 |
In Vitro and In Vivo Suppression of Osteoclast Function by Adenovirus Vector-Induced csk Gene
T Miyazaki, H Takayanagi, M Isshiki, T Takahashi, M Okada, Y Fukui, H Oda, K Nakamura, H Hirai, T Kurokawa, S Tanaka |
Journal of Bone and Mineral Research | 2000 |
Superoxide generation and tyrosine kinase
S Yang, M Hardaway, G Sun, WL Ries, LL Key |
Biochemistry and Cell Biology | 2000 |
A Src SH2 selective binding compound inhibits osteoclast-mediated resorption
SM Violette, WC Shakespeare, C Bartlett, W Guan, JA Smith, RJ Rickles, RS Bohacek, DA Holt, R Baron, TK Sawyer |
Chemistry & Biology | 2000 |
Protein tyrosine kinase inhibitors increase cytosolic calcium and inhibit actin organization as resorbing activity in rat osteoclasts
H Kajiya, K Okabe, F Okamoto, T Tsuzuki, H Soeda |
Journal of Cellular Physiology | 2000 |
Emerging therapies for osteoporosis
M Gowen, JG Emery, S Kumar |
Expert Opinion on Emerging Drugs | 2000 |
Metabolic bone disease: Lessons from knockout mice
AC Karaplis |
Drug Development Research | 2000 |
Integrins and signaling in osteoclast function
LT Duong, P Lakkakorpi, I Nakamura, GA Rodan |
Matrix Biology | 2000 |
Decreased c-Src expression enhances osteoblast differentiation and bone formation
M Marzia, NA Sims, S Voit, S Migliaccio, A Taranta, S Bernardini, T Faraggiana, T Yoneda, GR Mundy, BF Boyce, R Baron, A Teti |
The Journal of Cell Biology | 2000 |
Structure-based design of an osteoclast-selective, nonpeptide src homology 2 inhibitor with in vivo antiresorptive activity
W Shakespeare, M Yang, R Bohacek, F Cerasoli, K Stebbins, R Sundaramoorthi, M Azimioara, C Vu, S Pradeepan, CM 3rd, C Haraldson, T Merry, D Dalgarno, S Narula, M Hatada, X Lu, MR van Schravendijk, S Adams, S Violette, J Smith, W Guan, C Bartlett, J Herson, J Iuliucci, M Weigele, T Sawyer |
Proceedings of the National Academy of Sciences | 2000 |
Gelsolin deficiency blocks podosome assembly and produces increased bone mass and strength
M Chellaiah, N Kizer, M Silva, U Alvarez, D Kwiatkowski, KA Hruska |
The Journal of Cell Biology | 2000 |
A CD36-Binding Peptide from Thrombospondin-1 Can Stimulate Resorption by Osteoclasts in Vitro
JA Carron, SC Wagstaff, JA Gallagher, WB Bowler |
Biochemical and Biophysical Research Communications | 2000 |
Specific Antagonists of NMDA Receptors Prevent Osteoclast Sealing Zone Formation Required for Bone Resorption
C Itzstein, L Espinosa, PD Delmas, C Chenu |
Biochemical and Biophysical Research Communications | 2000 |
Regulation of Collagenolytic Protease Secretion through c-Src in Osteoclasts
N Furuyama, Y Fujisawa |
Biochemical and Biophysical Research Communications | 2000 |
Osteoclast formation and resorption
UH Lerner |
Matrix Biology | 2000 |
Estrogen stimulates protein tyrosine phosphorylation and Src kinase activity in avian osteoclasts
KD Brubaker, CV Gay |
Journal of Cellular Biochemistry | 2000 |
Decreased C-Src Expression Enhances Osteoblast Differentiation and Bone Formation
M Marzia, NA Sims, S Voit, S Migliaccio, A Taranta, S Bernardini, T Faraggiana, T Yoneda, GR Mundy, BF Boyce, R Baron, A Teti |
The Journal of Cell Biology | 2000 |
Computational binding studies of human pp60c-src SH2 domain with a series of nonpeptide, phosphophenyl-containing ligands
DJ Price, WL Jorgensen |
Bioorganic & Medicinal Chemistry Letters | 2000 |
Mouse Genetics Have Uncovered New Paradigms in Bone Biology
T Günther, T Schinke |
Trends in Endocrinology & Metabolism | 2000 |
A neuro (endo)crine regulation of bone remodeling
M Amling, S Takeda, G Karsenty |
BioEssays | 2000 |
Study of the Nonresorptive Phenotype of Osteoclast-like Cells from Patients with Malignant Osteopetrosis: A New Approach to Investigating Pathogenesis
AM Flanagan, U Sarma, CG Steward, A Vellodi, MA Horton |
Journal of Bone and Mineral Research | 2000 |
A Novel Synthetic Triazolotriazepine Derivative JTT-606 Inhibits Bone Resorption by Down-Regulation of Action and Production of Bone Resorptive Factors
D Chikazu, M Shindo, T Iwasaka, M Katagiri, N Manabe, T Takato, K Nakamura, H Kawaguchi |
Journal of Bone and Mineral Research | 2000 |
Induction of c-Src in Human Blood Monocytes by Anti-CD98/FRP-1 mAb in an Sp1-Dependent Fashion
N Miyamoto, Y Higuchi, M Tsurudome, M Ito, M Nishio, M Kawano, A Sudo, K Kato, A Uchida, Y Ito |
Cellular Immunology | 2000 |
Progressive increase in bone mass and development of odontomas in aging osteopetrotic c-src-deficient mice
M Amling, L Neff, M Priemel, AF Schilling, JM Rueger, R Baron |
Bone | 2000 |
Breakthrough in bone: the molecular mechanism of osteoclast/osteoblast coupling revealed
EM Schwarz, RJ O'Keefe |
Current Opinion in Orthopedics | 2000 |
Structure-based design of an osteoclast-selective, nonpeptide Src homology 2 inhibitor with in vivo antiresorptive activity
W Shakespeare, M Yang, R Bohacek, F Cerasoli, K Stebbins, R Sundaramoorthi, M Azimioara, C Vu, S Pradeepan, C Metcalf, C Haraldson, T Merry, D Dalgarno, S Narula, M Hatada, X Lu, MR van Schravendijk, S Adams, S Violette, J Smith, W Guan, C Bartlett, J Herson, J Iuliucci, M Weigele, T Sawyer |
Proceedings of the National Academy of Sciences | 2000 |
Stimulatory effect of curcumin on osteoclast apoptosis
K Ozaki, Y Kawata, S Amano, S Hanazawa |
Biochemical Pharmacology | 2000 |
Active Recombinant Human Tyrosine Kinase c-Yes: Expression in Baculovirus System, Purification, Comparison to c-Src, and Inhibition by a c-Src Inhibitor
M Šuša, NH Luong-Nguyen, J Crespo, R Maier, M Missbach, G McMaster |
Protein Expression and Purification | 2000 |
Development of inhibitors for protein tyrosine kinases
FA Al-Obeidi, KS Lam |
Oncogene | 2000 |
Chimeric constructs containing the SH4/Unique domains of cYes can restrict the ability of Src527F to upregulate heme oxygenase-1 expression efficiently
JG Hoey, J Summy, DC Flynn |
Cellular Signalling | 2000 |
Rho-A Is Critical for Osteoclast Podosome Organization, Motility, and Bone Resorption
MA Chellaiah, N Soga, S Swanson, S McAllister, U Alvarez, D Wang, SF Dowdy, KA Hruska |
The Journal of biological chemistry | 2000 |
Evidence for a Functional Association between Phosphatidylinositol 3-Kinase and c-src in the Spreading Response of Osteoclasts to Colony-Stimulating Factor-1*
A Grey, Y Chen, I Paliwal, K Carlberg, K Insogna |
Endocrinology | 2000 |
Bone Resorption by Osteoclasts
SL Teitelbaum |
Science | 2000 |
A novel inhibitor of the tyrosine kinase Src suppresses phosphorylation of its major cellular substrates and reduces bone resorption in vitro and in rodent models in vivo
M Missbach, M Jeschke, J Feyen, K Müller, M Glatt, J Green, M Šuša |
Bone | 1999 |
Cell biology of the osteoclast
GD Roodman |
Experimental Hematology | 1999 |
Tumor Necrosis Factor-α Mediates Orthopedic Implant Osteolysis
KD Merkel, JM Erdmann, KP McHugh, Y Abu-Amer, FP Ross, SL Teitelbaum |
The American Journal of Pathology | 1999 |
Expression and Regulation of RAB3 Proteins in Osteoclasts and Their Precursors
Y Abu-Amer, SL Teitelbaum, JC Chappel, P Schlesinger, FP Ross |
Journal of Bone and Mineral Research | 1999 |
Tumor necrosis factor-alpha mediates orthopedic implant osteolysis
KD Merkel, JM Erdmann, KP McHugh, Y Abu-Amer, FP Ross, SL Teitelbaum |
The American Journal of Pathology | 1999 |
Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption
H Yoshitake, SR Rittling, DT Denhardt, M Noda |
Proceedings of the National Academy of Sciences | 1999 |
The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts
TL Burgess, Y Qian, S Kaufman, BD Ring, G Van, C Capparelli, M Kelley, H Hsu, WJ Boyle, CR Dunstan, S Hu, DL Lacey |
The Journal of Cell Biology | 1999 |
TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling
MA Lomaga, WC Yeh, I Sarosi, GS Duncan, C Furlonger, A Ho, S Morony, C Capparelli, G Van, S Kaufman, A der Heiden, A Itie, A Wakeham, W Khoo, T Sasaki, Z Cao, JM Penninger, CJ Paige, DL Lacey, CR Dunstan, WJ Boyle, DV Goeddel, TW Mak |
Genes & development | 1999 |
Gene expression during osteoclast-like cell formation induced by antifusion regulatory protein-1/CD98/4F2 monoclonal antibodies (MAbs): c-src is selectively induced by anti-FRP-1 MAb
Y Higuchi, M Ito, M Tajima, S Higuchi, N Miyamoto, M Nishio, M Kawano, S Kusagawa, M Tsurudome, A Sudo, K Katou, A Uchida, Y Ito |
Bone | 1999 |
TRANCE, a TNF Family Member, Activates Akt/PKB through a Signaling Complex Involving TRAF6 and c-Src
BR Wong, D Besser, N Kim, JR Arron, M Vologodskaia, H Hanafusa, Y Choi |
Molecular Cell | 1999 |
Structure-activity relationships of a novel class of Src SH2 inhibitors
JL Buchanan, CB Vu, TJ Merry, EG Corpuz, SG Pradeepan, UN Mani, M Yang, HR Plake, VM Varkhedkar, BA Lynch, IA MacNeil, KA Loiacono, CL Tiong, DA Holt |
Bioorganic & Medicinal Chemistry Letters | 1999 |
Structure-based design and synthesis of a novel class of Src SH2 inhibitors
JL Buchanan, RS Bohacek, GP Luke, M Hatada, X Lu, DC Dalgarno, SS Narula, R Yuan, DA Holt |
Bioorganic & Medicinal Chemistry Letters | 1999 |
Implications for Src Kinases in Hematopoiesis: Signal Transduction Therapeutics
S Sinha, SJ Corey |
Journal of Hematotherapy & Stem Cell Research | 1999 |
Mechanisms of Osteoclast Dysfunction in Human Osteopetrosis: Abnormal Osteoclastogenesis and Lack of Osteoclast-Specific Adhesion Structures
A Teti, S Migliaccio, A Taranta, S Bernardini, GD Rossi, M Luciani, M Iacobini, LD Felice, R Boldrini, C Bosman, A Corsi, P Bianco |
Journal of Bone and Mineral Research | 1999 |
Human malignant osteopetrosis: Pathophysiology, management and the role of bone marrow transplantation
A Fasth, O Porras |
Pediatric Transplantation | 1999 |
Advances in Amino Acid Mimetics and Peptidomimetics
TJ Tucker, RC Isaacs |
Advances in Amino Acid Mimetics and Peptidomimetics Volume 2 | 1999 |
Extensive Clear Zone and Defective Ruffled Border Formation in Osteoclasts of Osteopetrotic (ia/ia) Rats: Implications for Secretory Function
FP Reinholt, K Hultenby, D Heinegård, SC Marks, M Norgård, G Anderson |
Experimental Cell Research | 1999 |
C-terminal Src Kinase Associates with Ligand-stimulated Insulin-like Growth Factor-I Receptor
C Arbet-Engels, S Tartare-Deckert, W Eckhart |
The Journal of biological chemistry | 1999 |
Bisphosphonates in Clinical Oncology
B Thürlimann |
1999 | |
Src-Related Protein Tyrosine Kinases in Hematopoiesis
SJ Corey, SM Anderson |
Blood | 1999 |
Cloning and identification of human Sca as a novel inhibitor of osteoclast formation and bone resorption
SJ Choi, RD Devlin, C Menaa, H Chung, GD Roodman, SV Reddy |
Journal of Clinical Investigation | 1998 |
PYK2 in osteoclasts is an adhesion kinase, localized in the sealing zone, activated by ligation of alpha(v)beta3 integrin, and phosphorylated by src kinase
LT Duong, PT Lakkakorpi, I Nakamura, M Machwate, RM Nagy, GA Rodan |
Journal of Clinical Investigation | 1998 |
Expression of Src Family Kinases and Their Putative Substrates in the Human Preosteoclastic Cell Line FLG 29.1
M Jeschke, ML Brandi, M Šuša |
Journal of Bone and Mineral Research | 1998 |
Cloning and identification of human Sca as a novel inhibitor of osteoclast formation and bone resorption
SJ Choi, RD Devlin, C Menaa, H Chung, GD Roodman, SV Reddy |
Journal of Clinical Investigation | 1998 |
A beta 1 integrin signaling pathway involving Src-family kinases, Cbl and PI-3 kinase is required for macrophage spreading and migration
F Meng, CA Lowell |
The EMBO Journal | 1998 |
Bone resorption caused by three periodontal pathogens in vivo in mice is mediated in part by prostaglandin
Y Zubery, CR Dunstan, BM Story, L Kesavalu, JL Ebersole, SC Holt, BF Boyce |
Infection and immunity | 1998 |
Age-resolving osteopetrosis: a rat model implicating microphthalmia and the related transcription factor TFE3
KN Weilbaecher, CL Hershey, CM Takemoto, MA Horstmann, TJ Hemesath, AH Tashjian, DE Fisher |
Journal of Experimental Medicine | 1998 |
SRC64 Regulates the Localization of a Tec-Family Kinase Required for Drosophila Ring Canal Growth
DJ Guarnieri, GS Dodson, MA Simon |
Molecular Cell | 1998 |
WISKOTT-ALDRICH SYNDROME: CURRENT RESEARCH CONCEPTS
PM Brickell, DR Katz, AJ Thrasher |
British Journal of Haematology | 1998 |
Protein tyrosine kinases: Structure, substrate specificity, and drug discovery
FA Al-Obeidi, JJ Wu, KS Lam |
Biopolymers | 1998 |
Colony Stimulating Factor-1-Induced Osteoclast Spreading Depends on Substrate and Requires the Vitronectin Receptor and the c-src Proto-Oncogene
A Teti, A Taranta, S Migliaccio, A Degiorgi, E Santandrea, I Villanova, T Faraggiana, M Chellaiah, KA Hruska |
Journal of Bone and Mineral Research | 1998 |
Commitment and differentiation of stem cells to the osteoclast lineage
SI Hayashi, T Yamane, A Miyamoto, H Hemmi, H Tagaya, Y Tanio, H Kanda, H Yamazaki, T Kunisada |
Biochemistry and Cell Biology | 1998 |
Age-resolving Osteopetrosis: A Rat Model Implicating Microphthalmia and the Related Transcription Factor TFE3
KN Weilbaecher, CL Hershey, CM Takemoto, MA Horstmann, TJ Hemesath, AH Tashjian, DE Fisher |
Journal of Experimental Medicine | 1998 |
Advances in Organ Biology
AJ Liedtke |
Advances in Organ Biology | 1998 |
Sphingomyelinase and ceramide inhibit formation of F-actin ring in and bone resorption by rabbit mature osteoclasts
H Takeda, K Ozaki, H Yasuda, M Ishida, S Kitano, S Hanazawa |
FEBS Letters | 1998 |
Metabolic Bone Disease and Clinically Related Disorders
FR Singer, SM Krane |
Metabolic Bone Disease and Clinically Related Disorders | 1998 |
The protein tyrosine kinase p60c-Src is not implicated in the pathogenesis of the human autosomal recessive form of osteopetrosis: A study of 13 children
F Bernard, JL Casanova, G Cournot, N Jabado, J Peake, S Jauliac, A Fischer, C Hivroz |
The Journal of Pediatrics | 1998 |
Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice
T Xu, P Bianco, LW Fisher, G Longenecker, E Smith, S Goldstein, J Bonadio, A Boskey, AM Heegaard, B Sommer, K Satomura, P Dominguez, C Zhao, AB Kulkarni, PG Robey, MF Young |
Nature Genetics | 1998 |
Histomorphometric Evidence for Echistatin Inhibition of Bone Resorption in Mice with Secondary Hyperparathyroidism
P Masarachia, M Yamamoto, CT Leu, G Rodan, L Duong |
Endocrinology | 1998 |
c-Src Is Required for Stimulation of Gelsolin-associated Phosphatidylinositol 3-Kinase
M Chellaiah, C Fitzgerald, U Alvarez, K Hruska |
The Journal of biological chemistry | 1998 |
Tumor Necrosis Factor-α Activation of Nuclear Transcription Factor-κB in Marrow Macrophages Is Mediated by c-Src Tyrosine Phosphorylation of IκBα
Y Abu-Amer, FP Ross, KP McHugh, A Livolsi, JF Peyron, SL Teitelbaum |
The Journal of biological chemistry | 1998 |
Tyrosine Phosphorylation of p130 Cas Is Involved in Actin Organization in Osteoclasts
I Nakamura, E Jimi, LT Duong, T Sasaki, N Takahashi, GA Rodan, T Suda |
The Journal of biological chemistry | 1998 |
Novel Approaches to Treatment of Osteoporosis
RG Russell, TM Skerry, U Kollenkirchen |
1998 | |
Bone Resorption Caused by Three Periodontal Pathogens In Vivo in Mice Is Mediated in Part by Prostaglandin
JR McGhee, Y Zubery, CR Dunstan, BM Story, L Kesavalu, JL Ebersole, SC Holt, BF Boyce |
Infection and immunity | 1998 |
Src64 is required for ovarian ring canal morphogenesis during Drosophila oogenesis
GS Dodson, DJ Guarnieri, MA Simon |
Development (Cambridge, England) | 1998 |
Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor
Y Abu-Amer, FP Ross, J Edwards, SL Teitelbaum |
Journal of Clinical Investigation | 1997 |
Colony-stimulating factor-1 induces cytoskeletal reorganization and c-src-dependent tyrosine phosphorylation of selected cellular proteins in rodent osteoclasts
KL Insogna, M Sahni, AB Grey, S Tanaka, WC Horne, L Neff, M Mitnick, JB Levy, R Baron |
Journal of Clinical Investigation | 1997 |
Osteoporosis
DL Glaser, FS Kaplan |
Spine | 1997 |
Overview of bisphosphonates
MJ Rogers, DJ Watts, RG Russell |
Cancer | 1997 |
Regulation of Osteoclast Function
T Suda, I Nakamura, E Jimi, N Takahashi |
Journal of Bone and Mineral Research | 1997 |
The localization of CD44 and moesin in osteoclasts after calcitonin administration in mouse tibiae
H Nakamura, M Yamada, M Fukae, H Ozawa |
Journal of Bone and Mineral Metabolism | 1997 |
Substrate recognition by osteoclast precursors induces C-src/microtubule association
Y Abu-Amer, FP Ross, P Schlesinger, MM Tondravi, SL Teitelbaum |
The Journal of Cell Biology | 1997 |
Requirement for NF-kappaB in osteoclast and B-cell development
G Franzoso, L Carlson, L Xing, L Poljak, EW Shores, KD Brown, A Leonardi, T Tran, BF Boyce, U Siebenlist |
Genes & development | 1997 |
Rescue of osteoclast function by transgenic expression of kinase-deficient Src in src-/- mutant mice
PL Schwartzberg, L Xing, O Hoffmann, CA Lowell, L Garrett, BF Boyce, HE Varmus |
Genes & development | 1997 |
Integrins and osteoclast polarization
SL Teitelbaum, H Tanaka, H Mimura, M Inoue, M Shima, A Shioi, M Chiba, S Kitazawa, FP Ross |
Osteoporosis International | 1997 |
CELLULAR FUNCTIONS REGULATED BY SRC FAMILY KINASES
SM Thomas, JS Brugge |
Annual Review of Cell and Developmental Biology | 1997 |
Osteoclast precursors in bone marrow and peritoneal cavity
SI Hayashi, A Miyamoto, T Yamane, H Kataoka, M Ogawa, S Sugawara, S Nishikawa, SI Nishikawa, T Sudo, H Yamazaki, T Kunisada |
Journal of Cellular Physiology | 1997 |
Role of c-Src in cellular events associated with colony-stimulating factor-1-induced spreading in osteoclasts
K Insogna, S Tanaka, L Neff, W Horne, J Levy, R Baron |
Molecular Reproduction and Development | 1997 |
Phosphatidylinositol-3 kinase is involved in ruffled border formation in osteoclasts
I Nakamura, T Sasaki, S Tanaka, N Takahashi, E Jimi, T Kurokawa, Y Kita, S Ihara, T Suda, Y Fukui |
Journal of Cellular Physiology | 1997 |
Alendronate inhibition of protein-tyrosine-phosphatase-meg1
EE Opas, SJ Rutledge, E Golub, A Stern, Z Zimoio, GA Rodan, A Schmidt |
Biochemical Pharmacology | 1997 |
1,25-dihydroxyvitamin D3 regulates pp60c-src activity and expression of a pp60c-src activating phosphatase
J Chappel, F P Ross, Y Abu-Amer, A Shaw, S L Teitelbaum |
Journal of Cellular Biochemistry | 1997 |
Design, Synthesis, and Cocrystal Structure of a Nonpeptide Src SH2 Domain Ligand
MS Plummer, DR Holland, A Shahripour, EA Lunney, JH Fergus, JS Marks, P McConnell, WT Mueller, TK Sawyer |
Journal of Medicinal Chemistry | 1997 |
Bisphosphonates: mechanisms of action
GA Rodan, HA Fleisch |
Journal of Clinical Investigation | 1996 |
Molecular aspects of osteoclast function
TJ Hall, TJ Chambers |
Inflammation Research | 1996 |
Development and characterization of a porcine model to study osteoclast differentiation and activity
RJ Galvin, P Bryan, JW Horn, MK Rippy, JE Thomas |
Bone | 1996 |
Variable effects of tyrosine kinase inhibitors on avian osteoclastic activity and reduction of bone loss in ovariectomized rats
HC Blair, SE Jordan, TG Peterson, S Barnes |
Journal of Cellular Biochemistry | 1996 |
Wiskott–Aldrich syndrome protein (WASp) is a binding partner for c-Src family protein-tyrosine kinases
S Banin, O Truong, DR Katz, MD Waterfield, PM Brickell, I Gout |
Current Biology | 1996 |
Regulatory mechanisms of osteoclast differentiation and function
GR Mundy |
Journal of Bone and Mineral Metabolism | 1996 |
Immunolocalization of CD44 and the ERM family in bone cells of mouse tibiae
H Nakamura, H Ozawa |
Journal of Bone and Mineral Research | 1996 |
Human blood-mobilized hematopoietic precursors differentiate into osteoclasts in the absence of stromal cells
A Matayoshi, C Brown, JF DiPersio, J Haug, Y Abu-Amer, H Liapis, R Kuestner, R Pacifici |
Proceedings of the National Academy of Sciences | 1996 |
Bacterially induced bone destruction: mechanisms and misconceptions
SP Nair, S Meghji, M Wilson, K Reddi, P White, B Henderson |
Infection and immunity | 1996 |
Protein-tyrosine phosphatase activity regulates osteoclast formation and function: inhibition by alendronate
A Schmidt, SJ Rutledge, N Endo, EE Opas, H Tanaka, G Wesolowski, CT Leu, Z Huang, C Ramachandaran, SB Rodan, GA Rodan |
Proceedings of the National Academy of Sciences | 1996 |
Molecular cloning and expression of a unique rabbit osteoclastic phosphotyrosyl phosphatase
LW Wu, DJ Baylink, KH Lau |
Biochemical Journal | 1996 |
Cytoskeletal changes in osteoclasts during the resorption cycle
PT Lakkakorpi, HK Väänänen |
Microscopy Research and Technique | 1996 |
Activation of human pp60c-src
JD Bjorge, TJ O'Connor, DJ Fujita |
Biochemistry and Cell Biology | 1996 |
Regulation, substrates and functions of src
MT Brown, JA Cooper |
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer | 1996 |
Mechanism of osteoclast-mediated bone resorption
HK Väänänen, J Salo, P Lehenkari |
Journal of Bone and Mineral Metabolism | 1996 |
Animal models of osteopetrosis: the impact of recent molecular developments on novel strategies for the therapeutic intervention
SN Popoff, GB Schneider |
Molecular Medicine Today | 1996 |
Identification of a Novel 135-kDa Grb2-binding Protein in Osteoclasts
M Sahni, XM Zhou, L Bakiri, J Schlessinger, R Baron, JB Levy |
The Journal of biological chemistry | 1996 |
Stimulation of Mouse Osteopontin Promoter by v-Src Is Mediated by a CCAAT Box-binding Factor
K Tezuka, DT Denhardt, GA Rodan, S Harada |
The Journal of biological chemistry | 1996 |
Increased bone formation in osteocalcin-deficient mice
P Ducy, C Desbois, B Boyce, G Pinero, B Story, C Dunstan, E Smith, J Bonadio, S Goldstein, C Gundberg, A Bradley, G Karsenty |
Nature | 1996 |
c-Cbl is downstream of c-Src in a signalling pathway necessary for bone resorption
S Tanaka, M Amling, L Neff, A Peyman, E Uhlmann, JB Levy, R Baron |
Nature | 1996 |
The Molecular Biology of Paget’s Disease
PT Sharpe |
1996 | |
Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo
DE Hughes, KR Wright, HL Uy, A Sasaki, T Yoneda, DG Roodman, GR Mundy, BF Boyce |
Journal of Bone and Mineral Research | 1995 |
The heterogeneity of the osteopetroses reflects the diversity of cellular influences during skeletal development
SN Popoff, SC Marks |
Bone | 1995 |
Differentiation dependent expression of tensin and cortactin in chicken osteoclasts
K Hiura, SS Lim, SP Little, S Lin, M Sato |
Cell Motility and the Cytoskeleton | 1995 |
Possible involvement of focal adhesion kinase, p125FAK, in osteoclastic bone resorption
S Tanaka, N Takahashi, N Udagawa, H Murakami, I Nakamura, T Kurokawa, T Suda |
Journal of Cellular Biochemistry | 1995 |
Porphyromonas gingivalis fimbria-stimulated bone resorption in vitro is inhibited by a tyrosine kinase inhibitor
S Hanazawa, Y Kawata, Y Murakami, K Naganuma, S Amano, Y Miyata, S Kitano |
Infection and immunity | 1995 |
Engagement of the Osteoclast Integrin ?v?3by Osteopontin Stimulates Phosphatidylinositol 3-Hydroxyl Kinase Activityb
KA Hruska, F Rolnick, M Huskey, U Alvarez, D Cheresh |
Annals of the New York Academy of Sciences | 1995 |
Signalling by the p60c-src family of protein—tyrosine kinases
P Kefalas, TR Brown, PM Brickell |
The International Journal of Biochemistry & Cell Biology | 1995 |
Targeting the mouse genome: a compendium of knockouts (part III)
EP Brandon, RL Idzerda, GS McKnight |
Current Biology | 1995 |
Wortmannin, a specific inhibitor of phosphatidylinositol-3 kinase, blocks osteoclastic bone resorption
I Nakamura, N Takahashi, T Sasaki, S Tanaka, N Udagawa, H Murakami, K Kimura, Y Kabuyama, T Kurokawa, T Suda, Y Fukui |
FEBS Letters | 1995 |
Wortmannin, a potent inhibitor of phosphatidylinositol 3-kinase, inhibits osteoclastic bone resorption in vitro
TJ Hall, H Jeker, M Schaueblin |
Calcified Tissue International | 1995 |
Mycotrienins
D Feuerbach, R Waelchli, T Fehr, JH Feyen |
The Journal of biological chemistry | 1995 |
Association of the amino-terminal half of c-Src with focal adhesions alters their properties and is regulated by phosphorylation of tyrosine 527
KB Kaplan, KB Bibbins, JR Swedlow, M Arnaud, DO Morgan, HE Varmus |
The EMBO Journal | 1994 |
A novel monoclonal antibody recognizing a unique antigen of rat osteoclasts induced by the calcified matrices
K Hata, A Akamine, T Kukita, T Iijima, A Kukita, K Kurisu |
Histochemistry | 1994 |
Soluble alpha v beta 3-integrin ligands raise [Ca2+]i in rat osteoclasts and mouse-derived osteoclast-like cells
Z Zimolo, G Wesolowski, H Tanaka, JL Hyman, JR Hoyer, GA Rodan |
American journal of physiology. Cell physiology | 1994 |
The effects of bisphosphonates on the resorption cycle of isolated osteoclasts
K Selander, P Lehenkari, HK Vnnen |
Calcified Tissue International | 1994 |
Metastatic Bone Disease
IJ Diel, M Kaufmann, G Bastert |
1994 | |
PEPTIDES AND GROWTH REGULATORY FACTORS IN BONE
GR Mundy |
Rheumatic diseases clinics of North America | 1994 |
Identification of a hormonally regulated protein tyrosine phosphatase associated with bone and testicular differentiation
LJ Mauro, EA Olmsted, BM Skrobacz, RJ Mourey, AR Davis, JE Dixon |
The Journal of biological chemistry | 1994 |
Herbimycin A, a pp60c-src tyrosine kinase inhibitor, inhibits osteoclastic bone resorption in vitro and hypercalcemia in vivo
T Yoneda, C Lowe, CH Lee, G Gutierrez, M Niewolna, PJ Williams, E Izbicka, Y Uehara, GR Mundy |
Journal of Clinical Investigation | 1993 |
Cytokines and growth factors in the regulation of bone remodeling
GR Mundy |
Journal of Bone and Mineral Research | 1993 |
Role of cytokines in bone resorption
GR Mundy |
Journal of Cellular Biochemistry | 1993 |
Osteopetrosis in Src-deficient mice is due to an autonomous defect of osteoclasts
C Lowe, T Yoneda, BF Boyce, H Chen, GR Mundy, P Soriano |
Proceedings of the National Academy of Sciences | 1993 |
Histomorphometric and immunocytochemical studies of src-related osteopetrosis
BF Boyce, H Chen, P Soriano, GR Mundy |
Bone | 1993 |
Accumulation of high level of pp60c-srcN is an early event during GM3-antibody mediated differentiation of neuro-2a neuroblastoma cells
M Chakraborty, GM Anderson, A Chakraborty, D Chatterjee |
Brain Research | 1993 |
Cellular and Molecular Biology of Bone
M Demay, H Jüppner, AB Abou-Samra, G Segre, H Kronenberg |
Cellular and Molecular Biology of Bone | 1993 |
Lysosomes
G Weissmann |
New England Journal of Medicine | 1965 |